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ABSTRACT 
 
Challenges in treating injuries, together with an increased need for repair of damaged tissues 
and organs, have made regenerative medicine a major research area today. Biomaterials such 
as silk fibroin (SF) have proven to be excellent tissue scaffolds possessing properties 
essential in tissue engineering such as biocompatibility, biodegradability and exceptional 
mechanical properties. SF nanofibres are especially attractive due to their large surface-to-
volume ratio and high porosity which is beneficial in regenerative medicine. However, to 
design biomaterial scaffolds, chemical and physical properties of SF have to be sufficiently 
known. The thesis aims to contribute to knowledge by characterizing silk fibroin from the 
African wild silkworm species Gonometa rufobrunnae, Gonometa postica, Argema mimosae, 
Epiphora bahuniae and Anaphe panda. Moreover, the feasibility of producing nanofibrous 
biomaterial scaffolds from these fibroins is explored. 
The chemical composition of degummed fibres was investigated using Capillary 
electrophoresis whilst Infrared (IR) and Raman spectroscopic techniques were utilized to 
determine structural characteristics of the fibroin. In addition, thermal behaviour and 
mechanical properties of the fibroins were also investigated.  Nanofibres were fabricated via 
electrospinning. The effects of solution concentration, voltage, polymer flow rate and tip to 
collector distance were studied to give optimum electrospinning conditions. IR spectroscopy 
was also utilized to observe the conformational structure of the degummed and electrospun 
fibres whilst scanning electron microscopy (SEM) provided information on the size and 
morphology of the fibres. The use of the nanofibres as biomaterials was evaluated using 
cytotoxicity tests.  
Results showed that glycine, alanine and serine constituted over 70% of the amino acid 
composition of all the fibroins. Gonometa fibroin had more glycine than alanine whilst the 
opposite was true for Argema mimosae, Epiphora bahuniae and Anaphe panda fibroin. The 
abundance of basic amino acids in Gonometa rufobrunnae, Gonometa postica, Argema 
mimosae and Epiphora bahuniae fibroin makes them prime candidates for cell and tissue 
culture. The amino acid composition of the fibroins influenced secondary structure as the β-
sheet structure. Anaphe panda, Argema mimosae and Epiphora bahuniae silks was made up 
of mostly alanine-alanine (Ala-Ala)n polypeptides whilst Gonometa fibroin had an interesting 
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mixture of both glycine-alanine (Gly-Ala)n and (Ala-Ala)n units. The unique structures 
impacted the mechanical and thermal properties of the fibroins.  
Production of Gonometa nanofibres was mainly dependent on fibroin solution concentration. 
A minimum of 27 % w/v was needed to produce defect free nanofibres. Diameters of the 
electrospun fibres produced ranged from 300 to 2500 nm. IR spectroscopy data highlighted 
that the β-sheet conformation of degummed fibroin was degraded during the formation of the 
nanofibres rendering them water soluble. It was however possible to regenerate the β-sheet 
structure in the nanofibres by exposing them to various solvents. Cytotoxicity tests using 
Sulforhodamine B (SRB) assay demonstrated that the nanofibres were not toxic to cells, a 
major prerequisite for use as a biomaterial. 
This thesis successfully provides useful data in an area that has been minimally explored. 
Results suggest that SF from African silkworm species offers diversity in properties and are 
therefore attractive for use as biomaterials, especially in cell and tissue engineering. As far as 
we could determine, we are the first to extend the use of fibroin from African silk species by 
producing Gonometa SF nanofibres that are of potential use as biomaterial scaffolds.  
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CHAPTER ONE 
1.1 General Introduction 
Numerous innovative designs and technologies that have contributed to the improvement of 
human life have been derived from imitating materials found in nature. Observation of 
shelled creatures and architectural structures has resulted in the development of body armour 
and net materials (e.g. fishing nets, bandages, sieves) respectively [1].  Most of these natural 
materials are protein and polysaccharide polymers arranged individually or as composites 
with other elements or minerals to obtain various functionalities [2]. These polymers are 
hierarchically organized to dimensions as low as nanoscale level and exhibit several 
appealing properties for material scientists. Industries are thus targeting natural polymers, 
especially those patterned at nano level, for use in numerous medical and technical 
applications. Silk, collagen, elastin and keratin are some of the protein biopolymers that serve 
a variety of purposes in nature, mostly as structural materials in various systems [3]. Silks in 
particular are produced by spiders and several insect species, mostly as building materials for 
a wide variety of purposes [4]. The most well-known types are from the spiders due to their 
unparalleled mechanical strength [5] and silkworm which has been valued as a luxury textile 
fibre for many centuries [6]. Like other natural polymers, silk fibres show considerable 
variability dependent on the species, silk spinning conditions and the environment of the 
animals [7, 8]. The increased knowledge of silkworm silk properties and processing has 
contributed to it being rated as an excellent biopolymer for the development of biomedical 
devices. The possibilities presented by the silk at nanoscale levels have the potential to 
revolutionize the field of tissue engineering.  
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1.2  Background  
A greater need for repair of damaged tissues and organs has demanded innovations centred 
on bio-based materials. Biomaterials are prized for their inherent properties such as 
biocompatibility, non-toxicity and biodegradability which are critical for biomedical and 
biotechnological designs. There has thus been increased interest in natural fibres, especially 
proteins and polysaccharides, which possess biomaterial properties that can be of use in the 
biomedical and biotechnology sectors [9, 10]. Amongst the natural protein fibres, silk fibroin 
has emerged as one of the most promising biomaterials for human tissue engineering and/or 
regeneration. SF offers a unique combination of features that are unmatched by most other 
biopolymers. Its highly impressive mechanical properties provide support for regeneration of 
various tissues coupled with good biocompatibility, low inflammatory response, good gas 
permeability and tailored biodegradation [11]. 
 
Versatility in processing and chemical modification options offered by SF strengthens its 
preferential use in applications requiring biocompatible polymeric materials. Broad 
applicability of SF can also be realized through utilization of different formats such as films, 
hydrogels, powders, foams, micro and nanoparticles, membranes and 3D-scaffolds [11-13]. 
Three dimensional porous materials, particularly in the form of nanofibres, have greater 
potential as scaffolds for tissue engineering compared to two dimensional ones. Strongly 
resembling the natural extracellular matrix (ECM) of organisms, the high porosity and large 
surface area of nanofibres allows for cell attachment, transport of nutrients and gaseous 
exchange. In addition, a broad range of activity can be introduced into the nanofibre matrix 
by functionalizing or adding single or multiple bioactive components such as antibiotics, 
antimicrobials and growth factors [14, 15].   
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Amongst the techniques used for producing three dimensional nanostructured materials, 
electrospinning outclasses the rest due to its simplicity, cost-effectiveness, ability to produce 
nanofibres from various types of polymers and scale up capability [16]. Several reviews have 
been published highlighting the vast opportunities offered by electrospinning [17-19]. 
Nanofibres produced from various biomaterials have proven to be excellent in many 
biomedical applications. SF electrospun nanofibre scaffolds in particular have been 
recommended for growth and repairing of various tissues such as blood vessels, skin, nerves, 
tendons, bone and cartilage [11, 14, 20]. 
 
1.3  Motivation of the study  
In order for fibroin to be effectively applied in various fields, there has to be a good 
understanding of its chemical and structural features which affect its performance. Studies 
conducted show that SF is generally a large molecular weight (200–350 kDa or more) 
polymer composed of 18 amino acids arranged mostly in repetitive hydrophobic domains 
interspaced with small hydrophilic regions [21]. SF from the domesticated Bombyx mori 
species has been extensively characterized over many decades [22-24] and as such it has been 
the most applied as a biomaterial. SF extracted from other species has displayed different 
chemical properties and variability in primary structures and physical properties [25].  This 
diversity has been attributed to distinctions in the amino acid sequences of the different silks. 
For example, Antheraea silks are composed primarily of alanine-alanine (Ala-Ala)n 
polypeptides whereas the B. mori silks are mainly comprised of glycine –alanine (Gly-Ala)n 
polypeptides [26]. 
 
Information on the diverse properties offered by SF from other species has resulted in 
increased interest in their use as biomaterials. Their performance in some biomaterial 
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applications has been found to be superior to B. mori SF owing to differences in their 
physicochemical properties. In one study, films prepared from A. mylitta fibroin showed 
better cell growth and proliferation than films made from B. mori fibroin [27]. This was 
attributed to a tripeptide sequence, arganine–glycine–aspartic acid present in A. mylitta and 
not in B. mori fibroin. In addition to performance, the type of SF has also been found to 
influence key processes such as dissolution [28] and also has an impact on biomaterial 
fabrication [29, 30]. The clear fact is that each type of silk therefore has to be studied 
extensively to assess its processing and potential use as a biomaterial as this varies between 
species.  
 
These and other studies highlighting the potential of silk other than that from B. mori have 
motivated research of less studied silks such as those from uncommon silkworm species, 
bees, scorpions and mites in order to identify the unique properties that may be valuable for 
biomaterial and/or textile applications [31-33]. Africa is home to a number of the less studied 
silkworm species from different families such as the Saturniidae, Thaumetopoeidae and 
Lasiocampidae families. Limited studies have focused on identifying their chemical and 
physical properties [34-36] and more have been from a biodiversity, entomological and 
textile perspective [37-41]. There have/has actually been no studies on the processing and 
fabrication of applicable biomaterial formats of silk fibroin from silkworm species 
indigenous to Africa; thus their use has not gone beyond textiles. Understanding properties 
and processing of silk fibroin from African species will be key in identifying their place in 
biomaterial and biotechnological applications. Moreover, it will extend knowledge of the 
relationship between structure and functional properties of natural fibrous polymers. 
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1.4 Objectives 
Against this background, the overall objective of the presented work was to determine the 
properties of silk fibroin from African silkworm species and to explore their potential use as 
biomaterials. This was achieved under the following specific objectives:  
 
1. Chemical and physical characterization of fibroin derived from the African silkworm 
species Gonometa rufobrunnae, Gonometa postica, Argema mimosae, Epiphora bahuniae 
and Anaphe panda  
2. Fabrication and characterization of electrospun nanofibres from fibroin derived from 
African silkworm species  
3. Application of fabricated fibroin nanofibres as biomedical scaffolds. 
 
1.5 Layout of the Thesis 
Chapter 1 introduces the work and presents the motivation and objectives for the work.  
Chapters 2 and 3 provide literature review. Chapter 2 focuses on reviewing work done on the 
characterization of silk proteins. It also discusses properties of silk fibroin that make it 
attractive as a biomaterial. Chapter 3 discusses the electrospinning technique and its use in 
the fabrication of SF nanofibres. The use of electrospun SF nanofibres in different 
applications is also discussed.  
Chapter 4 covers the experimental procedures and characterization techniques used in the 
study. 
Chapters 5 and 6 contain results of the experiments conducted in the study. Chapter 5 focuses 
on the results of the chemical and physical characterization of the African silk fibroins. 
Chapter 6 shows results on the electrospinning of Gonometa SF. We also present results on 
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adsorption of the natural polyphenol resveratrol onto silk nanofibres for potential biomedical 
application. 
Chapter 7 presents conclusions of the research undertaken in this study. Proposals are also 
put forward for recommended future work. 
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CHAPTER TWO 
SILK AND ITS PROPERTIES 
2.1 Introduction 
Silks are protein polymers that are spun into fibres by some arthropods such as silkworms, 
spiders, scorpions and mites [42, 43]. These organisms produce silks for different purposes 
such as protective shelters, structural supports and capturing food [42, 44]. Silkworms in 
particular spin silk cocoons for protection from environmental elements and predators during 
metamorphosis. Silkworm silk is the most explored due to its success in textiles, historical 
medical use and availability as compared to silks from other organisms [44]. Classification of 
silk producing moths is often according to their different families e.g. Bombycidae, 
Saturniidae, Lasiocampidae, Thaumetopoeidae, etc., as summarized in Table 2.1. Though 
there are over 400 species of silk moths found in the world [45], only a few have been 
successfully explored for commercial production of silk.  
Silk production is typically associated with Asia, where silk processing was first developed 
over 4,500 years ago in China. Commercial silks are broadly classified as mulberry 
(cultivated) silk and non-mulberry (wild) silk. The Bombyx mori species which feeds on 
mulberry leaves is the best example of cultivated silk. B. mori silkworms have the highest 
fibre production thus providing the bulk of commercial silk fibre to date [46]. However, the 
silks produced by wild silkworms have found a place in the global market because of their 
rare feel and colour [50]. Unlike the B. mori silkworms that are reared in a controlled 
environment and nutrition, the wild silkworms feed and spin cocoons on a variety of host 
plants in their natural habitats. The quality of silk they produce is different and mainly 
attributed to their polyphagous nature, which has been found to influence the type of cocoon 
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produced [51]. Most of the wild silks species are from the Saturniidae, Lasiocompidae and 
Thaumetopoeidae families such as Antheraea pernyi, Antheraea mylitta, Antheraea yamamai 
and Samia Cynthia ricini [52]. 
Table 2.1. Classification of some silkmoths found around the world 
 
Developing countries, including some in Africa, have taken up wild silk production to 
generate employment as part of poverty alleviation projects for poor rural societies. Africa is 
home to a number of wild silk species and some of them such as Gonometa postica, 
Gonometa rufobrunnae and Anaphe panda have shown they have potential use in the textile 
industry [37-39, 53, 54].   
Silkworm species Host plants Distribution Reference 
Bombycidae 
 
Bombyx mori 
B. mandarina 
 
 
Mulberry  
 
 
China, India, 
Japan, Korea 
 
 
[46] 
Saturniidae 
 
Antheraea mylitta 
 
 
A. assemensis 
 
 
 
Terminalia tomentosa, Terminalia arjuna, 
Shrea robusta 
 
Persea bombycina, Litsea polhantha, L. 
salicifolia,  L. citrate 
 
 
India, Korea, 
Japan,  
 
 
[47]  
Lasiocampidae 
 
Gonometa postica 
 
 
 
G. rufobrunnae 
 
 
Acacia erioloba, A. tortillis, A. mellifera, 
Burkea africana, Prosopis glandulosa, 
Brachystegia species 
 
Colophospermum mopane 
 
 
Southern Africa, 
Kenya 
 
Botswana, 
Zimbabwe, 
Namibia 
 
 
[37, 38] 
 
 
 
[37] 
Thaumetopoeidae 
 
Anaphe infracta , 
A. venata, 
A. panda 
A. 
reticulata 
A. moloneyi 
 
 
 
 
Bridelia minrantha,  Pseudolachnostylis 
maprouneifolia, Cynometra ulexandri, 
Triumfetta manrophylla    
 
 
Nigeria, 
Uganda, Kenya, 
Cameroon, 
Congo, and 
Togo 
 
 
[39, 48, 
49] 
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2.2 Composition of the silk thread  
Silk proteins are synthesized in specialized glands of the silkworm and fibres are formed by 
stretching the liquid silk through the head movement of the silkworm [55-57]. Sericin and 
fibroin are the two main proteins produced by the silkworm. Fibroin makes up the bulk of the 
silk fibre with almost 80% composition whilst sericin constitutes 20–30% of the silk fibre, 
depending on the species [55, 58]. The fibroin, which is made up of two bundle cores (called 
brins), is synthesized in the posterior silk gland and then transferred into the middle silk gland 
where it is stored prior to spinning.  Sericin is produced in the middle silk gland and is 
secreted into the lumen. It coats the fibroin during spinning and acts as a gum binder to 
maintain the structural integrity of the cocoon [55, 58]. The rest of the cocoon consists of 
other small proteins, waxes, fats, salts and ash [59].  
 
2.3 Chemical characterization of silk proteins 
Proteins are essentially polymers of different length amino acid chains. Every amino acid 
possesses three groups; an amine group, a carboxyl group and a hydrogen atom bound to an 
alpha-carbon. The fourth group is the side chain (“R” group) which varies from one amino 
acid to the other. The unique amino acid composition of proteins results in their different 
sizes, structural arrangement and chemical reactivity. Silk proteins can thus be identified by 
the type and quantity of amino acids in their structure.  
Chemical and structural studies on silk proteins have been primarily done on fragments 
isolated from B. mori species as early as the 1930s [60]. The same 18 amino acids have been 
identified in both sericin and fibroin. However, owing to the different roles of the two 
proteins, they have easily distinguishable chemical compositions. Fibroins generally have 
around 80% non-polar amino acids rendering them insoluble in hot water. B. mori fibroin has 
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a large average molecular weight comprised of a heavy (350 kDa) and light (25 kDa) chain. 
These chains are linked together through a disulphide bond and the glycoprotein P25 (30 
kDa). Each P25 protein is bound through hydrophobic interaction to six heavy and light 
chains [61, 62]. The H-chain has a highly repetitive sequence of approximately 5263 amino 
acid residues typically rich in glycine, alanine and serine [23]. The L-chain polypeptide has 
about 262 amino acid residues dominated by leucine, isoleucine, valine and acidic amino 
acids. Fibroin extracted from wild silkworms indicates similarity to B. mori fibroin in that the 
predominant amino acids are glycine, alanine and serine, though there is variability in 
composition and size of the protein. Datta and co-workers established that A. mylitta fibroin 
is composed of two similar sized polypeptides approximately 197 kDa each [25]. This 
assembly appears to be characteristic of silk secreted by the Saturniidae family where L-
fibroin and P25 are absent [63]. Table 2.2 shows the amino acid composition of fibroins from 
different silk species. 
Sericin has a very different composition from fibroin. Studies have shown more than 5 
different sized polypeptides ranging from 20 to over 300 kDa in both mulberry and non-
mulberry sericin [24, 65, 66]. Most of the amino acids in sericin have strong polar (hydroxyl, 
carboxyl and amino) side groups such as serine and aspartic acid. Similar to observations for 
fibroin, sericin from wild cocoons has shown differences to B. mori sericin (Table 2.3). 
Exposure to various external stresses and harsh environments has been one of the reasons 
cited for differences in chemical composition in mulberry and wild cocoons [66]. Diet and 
differing genetics have also been implicated as contributors to these differences [67]. 
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Table. 2.2. Amino acid composition of fibroins from different silk species 
 ND = not detected; - = not determined 
 
A few characterization studies on proteins from the African silk worm species have been 
reported in literature. The first report was by Freddi and co-workers conducted on Gonometa 
rufobrunnae [34]. The fibroin, typical to those from other species, had large amounts of 
glycine and alanine.   In the same study, G. rufobrunnae sericin also contained a lot of acidic 
and hydroxyl amino acids with serine being the most abundant amino acid. There has been 
also a report on the chemical composition and rheological behaviour of Gonometa postica 
fibroin extracted directly from the silkworm glands [70]. Part of the work presented in this 
thesis on the Gonometa species has also been published [71]. Some data on Anaphe panda 
silk has been recently reported by researchers in Kenya [72]. There is however still a lot of 
work that needs to be done regarding the study of the chemical composition of silk proteins 
from other African silkworm species such as A. mimosae and E. bahuniae. 
Amino acid  Mole (%) composition 
Bombyx 
mori [64] 
Anthereae 
mylitta [25] 
Philosamia 
cynthia ricini [64] 
Anaphe 
infracta [64] 
Gonometa 
rufobrunnae [34] 
Glycine 42.8 30.89 27.8 28.6 35.95 
Alanine  32.4 27.7 50.5 61.5 23.75 
Serine  14.7 13.72 7.0 5.80 12.88 
Tyrosine 11.8 9.37 10.7 2.85 5.11 
Arganine  0.90 3.4 3.81 1.76 6.07 
Aspartic acid
a 
1.73 5.39 4.48 2.13 7.06 
Glutamic acid
b 
1.74 1.26 1.23 1.93 1.84 
Threonine 1.51 3.4 0.72 0.52 1.08 
Proline 0.63 0.05 0.55 0.86 2.07 
Histidine 0.32 1.36 1.74 1.16 0.13 
Phenylalanine 1.15 0.21 0.35 0.28 0.53 
Valine 3.03 1.57 0.58 0.54 1.12 
Leucine 0.68 0.79 0.50 0.91 1.04 
Lysine 0.45 0.26 0.46 0.23 0.49 
Isoleucine 0.87 0.28 0.68 0.40 0.74 
Cystine 0.03 ND 0.01 0.01 0.06 
Tryptophan 0.36 ND 0.70 0.51 - 
Methionine 0.1 0.05 0.02 0.11 0.12 
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Table 2.3. Amino acid composition of sericin from different silk species 
ND = not detected; - = not determined   
2.3.1  Amino acid analysis 
The types and quantities of amino acids present in silk fibroin have a notable impact the 
physical and chemical properties of silks. This is because the amino acids influence 
sequencing which then determines protein orientation and conformation of the protein chains 
[73].  
Amino acid analysis (AAA) is therefore an important step in characterizing silks and 
typically involves four main steps; hydrolysis, derivatization, separation and data 
interpretation. Hydrolysis is the process of breaking down the peptide bonds in the protein to 
release individual amino acids reflecting the composition of the parent protein [74]. Acid 
Amino acid Mole (%) composition 
Bombyx mori 
(250kDa) [68] 
Antheraea  
mylitta 
[64] 
 
Cricula 
trifenestrata 
[69] 
Gonometa 
rufobrunnae 
[34] 
Glycine 14.3 14.91 20.8 20.59 
Alanine 5.5 2.73 5.9 11.52 
Serine 39.0 23.21 39.8 21.51 
Tyrosine 0.70 4.33 7.1 2.90 
Arganine 2.90 6.11 2.9 3.67 
Aspartic acid
a 
13.3 14.15 2.6 18.08 
Glutamic acid
b 
12.8 6.03 1.5 8.95 
Threonine 3.3 13.16 13.1 1.29 
Proline ND 1.09 2.5 1.55 
Histidine 1.0 2.41 - 1.06 
Phenylalanine 0.4 2.47 - 2.28 
Valine 0.7 0.79 - 1.80 
Leucine 0.5 0.55 1.1 2.13 
Lysine 5.4 2.01 0.7 1.13 
Isoleucine 0.2 0.39 0.8 1.41 
Cystine 0.1 Traces - Traces 
Tryptophan - - - - 
Methionine ND Traces - 0.16 
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hydrolysis using hydrochloric acid (HCl) is mostly used for protein/peptide hydrolysis. 
Derivatization involves modification of analytes with the aim of imparting more suitable 
analytical characteristics to the analytes [75]. Specifically in AAA, derivatization is done for 
detection purposes as most amino acids suffer from the lack of strong chromophores (for UV 
detection) or fluorophores (for fluorescence detection). Phenylisothiocyanate (PITC) is a very 
good derivatization reagent for amino acids forming a cyclic 3-phenyl-2-thiohydantoin (PTH) 
or phenylthiocarbamyl (PTC) labelled product [76, 77] detectable at 254 nm (maximum 
absorbance) using UV detection.  
Though all the stages highlighted above are important, this study focused more on the 
separation and quantification of the derivatized amino acids. Separation of amino acids in 
complex matrices such as fibroin presents challenges as amino acids share common aspects 
of their chemical structure and hence have similar chemical properties. Each has a carboxylic 
acid and an amino functional group attached to the same tetrahedral carbon atom. Variances 
are found in the nature of their side groups (R) such as long or short chain alkyl groups, 
phenyl groups or polar entities (Table 2.4).  
Early methods developed for the separation, detection and quantification of amino acids were 
based on ion exchange chromatography (IEC), high performance liquid chromatography 
(HPLC) and gas chromatography (GC) [78-80]. Capillary electrophoresis (CE) later became a 
well appreciated technique in amino acid profiling as it offers intrinsic advantages such as 
high separation efficiency, small sample volumes and low consumption of solvents [81-83]. 
CE is an electrophoretic separation technique that employs an electric field to separate 
charged ions. Partitioning is primarily based on differences in solute size and charge at a 
given pH [82]. 
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Table 2.4. Structure and properties of amino acids found in silk [84] 
 
The variances result in different migration velocities of the analytes when voltage is applied; 
thus they are separated as depicted in Figure 2.1a. However, separation solely based on 
charge to mass ratios is not very successful in separating neutral or similar structured amino 
Amino Acid Abbreviation R pKa-NH3
+
 pKa-CO2H pKa-Side chain 
Glycine  Gly -H 9.6 2.34 - 
Alanine  Ala -CH3 9.69 2.35 - 
Valine  Val -CH(CH3)2 9.62 2.32 - 
Leucine  Leu CH2CH(CH3)2 9.60 2.36 - 
Isoleucine  Ile CH(CH3)CH2CH3 9.68 2.36 - 
Phenylalanine  
Phe 
 
9.13 1.83 - 
Tryptophan  
Trp 
 
9.39 2.38 - 
Tyrosine  
Tyr 
 
9.11 2.20 10.07 
Histidine  
His 
 
9.17 1.82 6.0 
Serine  Ser CH2OH 9.15 2.21 - 
Threonine  Thr CH(CH3)-OH 10.43 2.63 - 
Methionine  Met CH2CH2SCH3 9.21 2.28 - 
Cysteine  Cys CH2SH 8.33 1.71 10.78 
Aspartic Acid  Asp CH2CO2H 9.82 2.09 3.86 
Glutamic Acid  Glu CH2CH2CO2H 9.67 2.19 4.25 
Asparagine  Asn CH2CONH2 8.08 2.02 - 
Glutamine  Gln CH2CH2CONH2 9.13 2.17 - 
Lysine  Lys (CH2)4NH2 8.95 2.18 10.53 
Arginine  
Arg 
 
9.04 2.17 12.48 
Proline  
Pro 
 
10.60 1.99 - 
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acids such as the isomers leucine and isoleucine which have almost identical pKa values 
(Table 2.4).  
 
 
 
 
 
 
 
 
 
 
 
Modified electrophoresis techniques such as micellar electrokinetic chromatography (MEKC) 
offer added advantages in the separation of complex mixtures comprised of acidic, neutral, 
and basic amino acids. MEKC makes use of charged micelles to separate neutral and charged 
analytes by means of a pseudo-micellar phase that is created through hydrophobic 
interactions between solute molecules and the surfactant [85]. Analytes migrate based on 
their partitioning between the bulk buffer solution and micelles thus adding selectivity in the 
separation process (Figure 2.1b). Iadarola et al. extensively reviewed MEKC as a separation 
tool for amino acids from various biological matrices [86]. The review highlights MEKC as a 
reliable analytical technique for the analysis of amino acids in real samples and it was 
therefore the method of choice for determining amino acid composition of silk proteins in this 
work.  
Figure 2.1. Illustration of separation in (a) CZE mode and improved resolution in (b) using 
MEKC mode 
 
  
16 
 
2.4 Primary and secondary structure of silk proteins  
The variation in amino acid composition between sericin and fibroin results in considerable 
differences in their primary and secondary configurations. Sericin is primarily amorphous and 
has no organized structure. Silk fibroin, on the other hand, is highly ordered due to a 
repetitive primary structure based predominantly on the amino acids glycine, alanine and 
serine [87, 88]. The recurring subunits of these short chain amino acids permit close packing 
between the molecular chains resulting in extensive crystalline regions in fibroin [87]. Most 
of the amino acid residues with bulky and polar side chains are found in the minor non-
crystalline (amorphous) areas. This region is made up of various disordered structures with 
varying degrees of hydrogen bonding [89]. The structures observed for SF in the solid state 
are the Silk I, Silk II and Silk III structures. These structures have been investigated using 
several analytical techniques that include X-ray diffraction [22, 90], electron diffraction [91-
93], conformational energy calculations [94, 95], Infrared spectroscopy [90, 96] and NMR 
[97-99].  
Of the three structures, Silk III is the relatively newly discovered structure. It is described as a 
threefold helical crystal structure adopted by fibroin at the air–water interface, separating the 
hydrophobic alanine residues from the hydrophilic serine residues [100-102]. The Silk I 
structure is that found in the silk gland before spinning and is water-soluble. This structure is 
unstable as it transforms to the more common Silk II structure when subjected to physical 
stress such as drawing and shearing or upon exposure to heat and organic solvents [103, 104].  
The lack of orientation and the ease with which Silk I converts to Silk II has made its study 
difficult though some researchers have proposed possible structural models for it [105].  
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The Silk II (β-sheet) structure is the dominant secondary structure of fibroin which is well 
documented as it has been thoroughly studied for decades. The key element of this structure 
is the extensive hydrogen bonding between adjacent polypeptide chains forming large 
interconnected sheets (Figure 2.2). Marsh et al. proposed the antiparallel hydrogen bonded 6-
sheet arrangement in which all of the polypeptide’s methyl groups are found on one side of 
the protein sheet for the Silk II structure of B. mori fibroin [22]. On the basis of this structure, 
Warwicker categorized fibroin from the different species into several groups. These groups 
have different intersheet spacings dependent on varying amounts of glycine and alanine in the 
crystalline areas [106].  
Figure 2.2. Interaction between polypeptide chains forming the β-sheet structure [109] 
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The general conclusion from various studies is that the repetitive regions of the Silk II 
crystalline structure of B. mori SF are made up of -Gly-Ala-Gly-X.n- units, with X as Ser or 
Tyr while those of the wild Saturniidae silks are mainly of polyalanine (Ala)n repeats 
[26,107,108].  
2.5 Physical properties of silk fibroin 
 Both the crystalline and amorphous regions play an important role in determining the 
physical properties of the silks. The crystalline domains are responsible for the strength and 
toughness of the fibroin as the high fraction of β-sheets reinforce the structure which 
contributes to the stability of silk. The amorphous domains allow the crystalline domains to 
orient under strain thereby introducing elasticity and flexibility and also further increasing the 
strength of the material [11, 110]. The overall result is silk fibres possessing exceptional 
mechanical properties as compared to other natural and synthetic fibres, which is one of their 
most outstanding features. The hydrophobic domains of fibroins also contribute to its thermal 
stability at very low as well as very high temperatures [110, 111].  
2.6 Silk fibroin as a biomaterial 
One of the more common definitions of a biomaterial is "any substance (other than a drug) or 
combination of substances synthetic or natural in origin, which can be used any time, as a 
whole or as a part of a system which treats, augments, or replaces any tissue, organ or 
function of the body"[112]. Fibroin originally found use as a biomaterial in suturing of 
wounds after surgeries [113]. With continued research, fibroin use has extended to other 
biotechnological and biomedical applications. This is mainly because, in addition to its 
excellent physical properties, silk fibroin possesses biocompatible properties that render it 
useful as a biomaterial as summarized in Figure 2.3.  
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Figure 2.3. Properties of silk fibroin 
 
Fibroin has exceptional biocompatibility, biodegradability, low inflammatory response and 
good oxygen/water vapour permeability [114-116]. Biocompatibility is a vital property for 
biomaterials to ensure biological integration without causing harm to the host organism. 
Fibroin prepared in different formats has shown biocompatibility and has been successful in 
culturing a number of cell types with good adhesion and growth, similar or enhanced when 
compared to other biomaterials [117-120]. 
To ensure the desired physiological integration of a biomaterial device, its biodegradability 
must match its intended function in the organism. As a protein, fibroin degrades in a 
biological environment as a result of proteolysis. The rate and extent of silk biodegradation 
reportedly varies with different proteolytic enzymes such as chymotrypsin, protease, actinase 
and carboxylase [114, 121, 122]. Degradation rate is variable, depending on factors such as 
structural and morphological features of the fibroin, processing conditions, characteristics of 
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the biological environment at the location of implantation, and presence of different 
mechanical and chemical stresses [123]. It can be concluded that properties such as 
biodegradability and biocompatibility are influenced by the molecular arrangement or 
conformation of the silk fibroin.  
2.7 Preparation of silk fibroin matrices for biomaterial applications 
 The chemical and material properties of silk fibroin allow it to be processed into a variety of 
formats with potential for surface modifications suiting a wide range of applications. Silk 
fibroin biomaterial formats are mostly made from silk fibroin solutions. These solutions can 
be obtained by dispersing liquid silk from the silk gland of matured larvae in water, or by 
dissolving degummed silk fibres from cocoons [124]. The latter method is more practical for 
yielding large quantities of silk at once, though a number of steps are involved in processing 
the cocoons. The initial step is degumming where sericin is separated from the fibroin. The 
sericin is easily removed due to its hydrophilic nature which renders it soluble in hot water, 
alkali or acid solutions. Sodium carbonate (Na2CO3) or sodium hydrogen carbonate 
(NaHCO3) solutions are typically used for degumming [125]. The degummed fibres are then 
washed and dried before dissolving them to yield a fibroin solution.   
Dissolution of SF is often challenging as solvent molecules have to penetrate and break down 
the highly crystallized structure of the protein. SF is therefore insoluble in common solvents 
such as water, dilute acids and alkalis. Traditional methods of fibroin dissolution employ 
concentrated solutions of  aqueous, organic and aqueous-organic solution of salts such as 
lithium thiocyanate (LiCNS), lithium bromide (LiBr), calcium chloride (CaCl2), zinc chloride 
( ZnCl2), and calcium nitrate (Ca(NO3)2) [126-128]. More recently, ionic liquids have proven 
to be effective environmentally friendly solvents in dissolving fibroin [129, 130].  
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After dissolution, the fibroin solution is subjected to filtration and dialysis to remove any 
debris and the salt ions to produce an aqueous fibroin solution. The ‘redissolved’ aqueous 
fibroin solution is often termed regenerated silk fibroin (RSF). From RSF, fibroin can be used 
alone, blended and/or functionalized with other materials to fabricate different formats such 
as films [ 131-133], membranes [134], hydrogels [135, 136], sponges [121], powders [137], 
3D scaffolds [138, 139], fibres and nanofibres [140-144].  
The properties of the silk fibroin greatly influence its preparation into the different applicable 
designs and also affect its performance as a biomaterial. Studies on the attachment and 
growth of fibroblast cells (L-929) on the matrices of silk fibroin made from B. mori and A. 
pernyi showed that A. pernyi silk fibroin exhibited better cell attachment and growth [145] A. 
pernyi fibroin molecules contain the arganine–glycine–aspartic acid (RGD) tri-peptide 
sequences and consist of more amino acids with positive charge, which favours cell 
attachment. Acharya et al. reported that A. mylitta films had better mechanical strength, lower 
hydrophilicity and better support for cell growth as compared to B. mori films [146, 147]. 
Each silk therefore has to be studied extensively to assess its potential use as a biomaterial as 
this varies from species to species. This, combined with the need for materials with varied 
functionality biomedical and biotechnological applications, has prompted the study of the 
chemical, physical and biomaterial properties of unstudied silks [148-150]. These unstudied 
species include many of those found in Africa that are subject to research in this work. 
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CHAPTER THREE 
ELECTROSPINNING AND SILK FIBROIN NANOFIBRES 
3.1 Introduction 
Fibres serve different purposes in nature and have also found use in numerous technological 
applications. When these fibres are reduced to nano-scale dimensions, new and/or improved 
physicochemical properties are realized such as high surface area to volume ratio, superior 
thermal and electrical properties and mechanical strength [18, 151]. Nanofibres have thus 
found application in various industries including reinforcement of composites [152], 
protective textiles [153], filtration [154], catalysis [155], tissue engineering [156, 157] energy 
storage [158], sensors [159] and enzyme immobilization [160].  
Table 3.1  Comparison of nanofibre fabricating techniques [161] 
Process Production scale Advantages  Disadvantages 
Drawing Laboratory Minimum equipment required Discontinuous process, 
difficult to control fibre 
dimensions 
Template 
synthesis 
Laboratory Different fibre dimensions easily 
achieved by using different 
templates 
Process cannot be scaled 
up from laboratory 
Phase 
separation 
Laboratory Minimum equipment required,  
Batch to batch consistency is easily 
achieved 
Limited to specific 
polymers 
Self assembly Laboratory Good for obtaining smaller 
nanofibres 
Complex process 
Electrospinning Laboratory and 
industrial scale 
Cost effective, 
wide applicability using both 
natural and synthetic polymers 
long continuous nanofibres can be 
produced 
Jet instability 
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Fabrication of nanofibres can be achieved using several techniques such as the template 
method [162], self assembly [163], phase separation [164], drawing [165], melt blowing 
[166], ultrasonic techniques [167], nanolithography [168] and electrospinning [157-159]. 
From a practical view point, most of the above mentioned techniques have limitations with 
respect to cost, production rate and the variety of polymers that can be processed (Table 3.1). 
Electrospinning is the only process that can easily produce large volumes of nanofibres from 
a wide range of synthetic and natural polymers at a reasonably low cost. It has thus become 
the most studied and developed nanostructuring technique by many tertiary and research 
institutes worldwide. Several companies worldwide, such as eSpin Technologies (United 
States) and Elmarco (Czech Republic), have harnessed this technology for materials 
production and have been successful in commercializing electrospun products [169-171].  
3.2 Background of electrospinning  
Electrospinning, originally termed electrostatic spinning, involves the generation of 
nanofibres from a polymer solution or melt using electrostatic force. Cooley and Moore filed 
patents that depicted apparatus for spraying of liquids using electrical charges over a 100 
years ago [172]. The more famous patent was filed by Formhals in which he described the 
electrospinning of plastics [173]. A few decades later, there was a renewed interest in the 
process with a discovery made by Taylor named after himself, the “Taylor cone”. This 
phenomenon is the deformation of the droplet at the end of the tip into a conical shape after 
application of the electrical field [174]. Reneker and co-workers then made significant 
contributions in understanding the process as they explored electrospinning of many different 
polymers [175, 176]. Over the years, knowledge and application of the process has evolved 
with continued research and development. Several review articles have been published 
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describing the numerous advancements that have been made in various aspects of the 
technique [177-179].   
3.3 Electrospinning setup and process 
The most basic electrospinning setup is shown in Figure 3.1. It consists of a high voltage 
power supply, syringe pump, collector, and a syringe fitted with a needle. The polymer 
solution or melt is pumped through the needle and charged with a large electric potential.  
When voltage is applied and the electric potential reaches a critical level, the electrostatic 
repulsion of the polymer solution overcomes the surface tension at the tip of the spinneret, 
and a fine jet of entangled polymer chains is drawn out [178]. This jet whips through the air 
towards the grounded target, creating a dry fibre that collects on the target as the solvent 
evaporates.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1. General electrospinning setup [180]   
  
25 
 
Characteristics such as nanofibre diameter and morphology can be controlled by varying 
parameters that affect the electrospinning process. These parameters include processing, 
solution and ambient conditions [161, 181]. These parameters interact and influence each 
other during the electrospinning process and have to be optimized for nanofibres to form. 
Table 3.2 highlights how these parameters have affected nanofibre formation using different 
polymers. 
Apart from the different parameters affecting electrospinning, some applications require 
tailoring of nanofibres to suit specific functions. Electrospinning offers multiple possibilities 
in fabricating customized nanofibrous structures by modification of components such as the 
needle system [193] and the collecting manifold [194]. 
 3.4 Electrospinning of silk fibroin 
In addition to its other attractive material properties, regenerated silk fibroin (RSF) is 
extrudable, making it a good candidate for electrospinning. It can also be easily chemically 
modified or blended with other polymers to improve electrospinnability. 
Early recorded reports on electrospinning of silk were by Zarkoob and co-workers where they 
prepared nanofibres from Bombyx mori silk and spider dragline silk from Nephila clavipes 
[195]. From then, Sukigara and co-workers successfully employed electrospinning to prepare 
silk nanofibres whilst also studying how the various electrospinning parameters impact on the 
properties of the nanofibres [184, 189, 196]. The studies determined that silk concentration 
was the most important parameter for successful fabrication of silk nanofibres [184]. 
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Table 3.2.    Parameters affecting electrospinning 
Parameters Condition Effect on fibre morphology References 
Solution 
parameters 
 
Viscosity 
 
 
 
 
 
 
Polymer 
concentration 
 
 
 
 
Molecular weight 
of polymer 
 
 
 
Conductivity 
 
 
 
Surface tension 
 
 
The viscosity of the solution is related to the extent of 
polymer chain entanglements in the solution that prevent 
the electrical jet from breaking up 
 
 
A minimum concentration is required for sufficient polymer 
chain entanglements within the solution necessary to 
maintain the continuity of the electrical jet  
 
Polymer length also influences the extent of polymer chain 
entanglements in the solvent 
 
An increase in conductivity of the solution allows for more 
charges to be carried by the electrospinning jet. 
 
Charges on the polymer solution must be high enough to 
overcome the surface tension of the solution. 
 
 
 
 
Increase in viscosity results in low bead generation and 
increase in fibre diameter. 
 
High viscosity hinders pumping of the polymer solution 
through the syringe needle 
 
 
 
Increase in fibre diameter with increase in concentration 
 
 
 
 
Reduction in the number of beads and droplets  with 
increase in molecular weight 
 
 
 
Decrease in fibre diameter with increase in conductivity 
 
 
 
No conclusive link, high surface tension results in 
instability of jets 
 
 
 
[182]  
 
 
[183]  
 
 
 
 
[184]  
 
 
 
 
[185]  
 
 
 
 
[186]  
 
 
 
[187]  
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Processing 
parameters 
 
Applied voltage 
 
 
 
Tip to collector 
distance 
 
 
 
Feed rate 
 
 
 
Electrostatic force applied must overcome the surface 
tension of the solution 
 
 
For independent fibres to form, sufficient distance is needed 
to allow time for the solvent to evaporate 
 
 
 
Feed rate should be proportional to the rate the polymer 
solution is ejected from the tip of the needle 
 
 
 
 
 
 
Decrease in fibre diameter with increase in voltage 
There is a greater tendency for beads formation with too 
low and too high voltage   
 
Beads generated when distance is too small or too large  
Increasing the distance results in a decrease of the 
average fibre diameter 
 
 
Decrease in fibre diameter with decrease in flow rate, 
generation of beads with too high flow rate 
 
 
 
 
[188]  
 
 
 
[189] 
 
 
 
 
[190]  
Ambient 
parameters 
Humidity  
 
 
Temperature 
 
 
- 
 
 
- 
 
 
High humidity results in circular pores in the fibres 
 
 
Increase in temperature results in decrease of fibre 
diameter 
 
 
[191]  
 
 
[192]  
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Though SF from a number of different silk species has been successfully electrospun, the 
electrospinnability has been greatly influenced by the type of silk as the molecular weight 
varies for different silk species. Ohgo et al. highlighted this when they found different 
spinning concentrations for B. mori, Samia Cynthia ricini and genetically engineered 
recombinant silk fibroins using hexafluoroacetone hydrate as an electrospinning solvent 
[197]. In other work, indigenous Thai silkworms (Nang-Lai) and Chinese/Japanese hybrid 
silkworms showed different electrospinnability [198]. In addition to differences in 
electrospinnability, B. mori silk fibroin, Tussah silk fibroin (TSF) and (SF/TSF) hybrid 
nanofibres showed differences in properties such as moisture absorption as well as cell 
attachment and spreading [199]. Other studies have shown that electrospinning of SF is also 
dependent on the processing methods used for regeneration of the silk. Wadbua and co-
workers reported different electrospinning concentrations when they electrospun nanofibres 
from separated light-chain and heavy-chain fibroins [200]. The nanofibres produced from 
light-chain and heavy chain fibroins also exhibited differences in properties such as 
hydrophilic nature, water uptake ability, degradation rate and cell adhesion. It is therefore 
important to study electrospinning of SF from different species individually as they may 
require different conditions to produce nanofibres and/or produce nanofibres exhibiting 
varied properties. 
Table 3.3 highlights extensive work done on electrospinning of SF, alone or blended with 
various polymers or active agents, for different applications and studies. The most utilized 
solvents for electrospinning silk fibroin shown in Table 3.3 include formic acid (FA), 
hexafluoro-2-propanol (HFIP), trifluoroacetic acid (TFA), hexafluoroacetone (HFA) and 
trifluoroethanol (TFE). The use of these harsh organic solvents was put under the spotlight 
for potentially compromising the biocompatibility and mechanical properties of the silk 
nanofibres.  
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Table 3.3. Examples of electrospinning of silk fibroin nanofibres and their applications 
Polymer(s) Additives Solvent(s) Application References 
B. mori SF & spider 
dragline silk  
- HFIP - [195]  
B. mori SF - 98-100% FA - [184, 201] 
B. mori, SF, S.C. 
ricini SF, hybrid silk 
- HFA  - [197] 
B. mori SF TMOS, (nHA)  HFIP, 
98% FA 
Bone tissue engineering [202] 
B. mori SF/Chitin - HFIP Wound healing/tissue 
engineering 
[203] 
B. mori SF Curcumin 100% TFA Drug delivery [204] 
B. mori SF - H2O - [205-207]  
B. mori SF/PEO - H2O Cell culture [208]  
B. mori SF - Imidazolium based 
ionic liquids 
- [209]  
B. mori SF/carbon 
nanotubes 
- Imidazolium based 
ionic liquids 
- [209]  
B. mori SF/ 
(MWNTs) 
- H2O Tissue engineering [210] 
B. mori SF/chitosan - HFIP,TFE - [211] 
B. mori SF/CA - TFA Heavy metal ion 
adsorption 
[212] 
B. mori SF - 98% FA Skin regeneration [213]  
SF/ PLA Aspirin TFA/ 
dichloromethane 
70/30) 
Drug delivery [214]  
B. mori SF/PEO Epidermal 
growth factor 
(EGF) 
H2O Wound healing [215]  
 
B. mori SF Vitamin C H2O Skin regeneration,  
Wound dressings, anti-
aging cosmetics. 
[216]  
 
B. mori SF/Chitosan - HFIP / TFA Wound dressing [217]  
B. mori SF/Chitosan - TFA/DCM (7:3) bone tissue engineering [218] 
A. pernyi SF - HFIP Tissue engineering [219] 
B. mori SF Au NPs, 
(RGD) peptide 
 Tissue engineering [220]  
 
SF, type I collagen, 
PLAGA  
- HFIP Tissue engineering [221]  
 
Thai B. mori and 
Chinese/Japanese 
Hybrid B. mori SF 
- 85% FA Bone tissue engineering [222]  
 
B. mori SF BMP-2 H2O Bone tissue engineering [223]  
 
B. mori & Thai SF - HFIP Nerve regeneration [224]  
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Tussah SF - 98% FA, HFIP Nerve tissue engineering [225]  
 
B. mori SF - 98-100% FA Enzyme immobilization [226] 
B. mori SF/gelatin - FA Blood vessel 
engineering 
[227]  
B. mori SF/PVA Ag   Antimicrobial scaffold [228]  
SF/SS -  - [229] 
B. mori silk gland 
SF/PEO 
Green 
fluorescent 
protein 
H2O  [230]  
TMOS = tetramethyl orthosilicate, (nHA )= nanohydroxyapatite, SWNTs = single walled nanotubes, 
MWNTs = multi-walled nanotubes, PLAGA = polylactic-co-glycolic acid, BMP-2 = bone 
morphogenetic protein-2, PLA = polylactic acid, PVA = polyvinyl alcohol, CA = cellulose acetate 
 
Although it has since been deduced that proper removal these solvents do not compromise the 
use of silk fibroin nanofibres in biological environments, the concern over them still resulted 
in studies being conducted to determine more ‘bio-friendly’ electrospinning solvents. Water 
was the solvent of choice and a number of researchers successfully electrospun fibroin 
aqueous solutions [205-207]. A general observation is that in aqueous media, higher SF 
concentrations are required for producing good nanofibres. Ionic liquids are powerful 
solvents that are considered to be environmentally friendly and some researchers have 
successfully utilized them for electrospinning silk fibroin [209].  
3.5 Post treatment of silk nanofibres 
The crystalline structure of fibroin is degraded during processing into regenerated silk fibroin 
(RSF) used to produce biomaterial formats such as nanofibres. RSF structure is mainly 
composed of α-helix and random coil conformations resulting in poor mechanical property 
and water resistance. Mechanical integrity is significant in many applications such as tissue 
and vessel engineering. RSF matrices therefore require post treatment mostly to restore 
and/or enhance their mechanical properties and water resistance. The common way of 
improving mechanical properties of silk fibroin matrices is by inducing crystallinity using 
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polar protonic organic solvents such as methanol, ethanol, propanol and isopropanol. The 
solvents bring about aggregation of the fibroin molecule chains resulting in structural 
transition from random coil and α-helix to mainly β-sheet conformation [231]. Improved 
mechanical properties have been observed for different SF matrices such as films [232] and 
nanofibres [143]. Methanol is widely reported as the most used solvent for treating SF 
matrices. It has however been found to induce crystallization of SF in an uncontrollable 
manner, forming extensive β-sheet structures which result in very brittle matrices [104]. 
Ethanol has been reported to have a similar but milder effect to methanol as the transition is 
to a smaller extent [143, 233]. Similar to immersion methods, solvent vapour treatment is 
also a fast and effective way to alter the secondary structure of SF nanofibres [104]. Water 
vapour also successfully induced structural transition comparable to the organic solvents. 
Time and temperature of the treatment were the influential parameters determining the extent 
of structural change [213]. 
 Recently, cross-linking agents such as glutaraldehyde and genipin have been used to achieve 
structural transition in SF matrices [234-236]. The advantage these compounds have is that 
they can be incorporated into the electrospinning thereby enabling conformational transition 
in one step and eliminating the post spinning treatment. The secondary structure of SF 
scaffolds is an important factor to consider as it has an impact on properties such as 
degradation [237], thermal behaviour [232], water absorption [134] as well as oxygen and 
water vapour permeability [134, 238]. Silk II is the most important and exploited structure in 
biomaterial applications as it can be tailored to suit various uses.  
Alternative to structural modification, blending of SF with other polymers can help improve 
mechanical properties. SF blend nanofibres with polyethylene oxide (PEO) [239], carbon 
nanotubes [209], chitosan [211] and cellulose acetate (CA) [212] all exhibited better 
mechanical properties as compared to pure SF nanofibres. Besides improving and/or 
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modifying structural and physical properties, post treatment for SF matrices can serve as a 
method for removing residual solvents used in the electrospinning process [30].  
3.6 Application of electrospun SF in wound healing  
Electrospun SF nanofibres find use in many applications such as those highlighted in Table 
3.3. Regenerative medicine is one of the major areas where there has been significant 
utilization of SF nanofibres. From a structural perspective, the porous three-dimensional 
nature of electrospun nanofibres resembles the nanoscale fibrous composition of the 
extracellular matrix (ECM) of living systems (Figure 3.2). The high surface area provided by 
nanofibres enables functions such as cell attachment and migration, which are key for 
regeneration of tissues and organs [240- 242]. The ECM is also composed of many proteins 
such as collagen, fibronectins, laminin and vitronectin thus making SF a prime material to be 
used in various facets of regenerative medicine.  
 
 
 
 
 
 
 
 
Figure 3.2. Structure of the extracellular matrix (ECM) surrounding cells in living tissues [243]  
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Several articles have highlighted the use of SF in many areas of regenerative medicine; 
however, this review will focus on its applications in wound healing and regeneration. 
Wound healing involves the restoration or regeneration of dermal and epidermal tissues after 
an individual has been wounded [244]. The healing process itself is complex and several 
aspects need to be carefully considered when trying to create an ideal wound dressing. 
However, the basic desirable properties for a wound dressing are to create an optimum 
environment to allow reepithelialisation, allow effective gaseous exchange and create a 
barrier against harmful microorganisms [245, 246]. 
 As wound dressings are in contact with biological environments, biopolymers are mostly 
more effective as wound dressings and accelerate the wound healing process compared to 
synthetic polymers [247]. One of the most important steps in wound healing is the closure of 
the wounded area by epithelial cells, a process that restores the epidermal barrier and protects 
the underlying tissue. Fibroin has shown potential in this regard by successfully supporting 
adhesion and growth of human keratinocytes which are the skin cells responsible for 
reepitheliazation of wounds [203, 213, 248, 249]. Fibroin has also been reported to promote 
growth and proliferation of human skin fibroblasts, which are also important in the wound 
healing process [249-253]. Min et al. further examined the effect of the nature of the SF 
matrices on the cell adhesion and spreading. They determined that the nanofibres are better 
suited for applications such as wound dressings and tissue engineering scaffolds than films 
and microfibre matrices [248].  
3.7 Bioactive agents in wound dressings 
For several decades, researchers have been searching for ways of improving the wound 
healing process. Advances in cellular and molecular biology have brought about knowledge 
that has made it possible for improvement and development of new therapies for treatment of 
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wounds. A major advancement are the new generation ‘smart’ wound dressings that 
incorporate single or a combination of therapeutic agents that can target different aspects of 
wound healing. The bioactive agents may be antibiotics [254], antibacterials [255], analgesics 
[256], growth factors [215], vitamins [216], antifungals [257], or a combination [258].   
There are, however, some current drawbacks in wound healing regarding some commonly 
used additives such as toxicity and increased antibiotic resistance. For example, silver is the 
active agent in several commercial antimicrobial wound dressings. However, it has been 
reported that prolonged use of silver particles and nanoparticles may be toxic to DNA and 
mitochondria [259, 260]. In addition to this, silver in wound dressings is the cause of some 
irritation and discoloration of wounds and surrounding tissue [261]. This therefore raises 
concerns regarding safety in long term use of silver. There are also major concerns regarding 
the increase of antibiotic resistant bacterial strains. Bacterial resistance has been observed 
with various groups of drugs such as tetracyclines, sulphonamides, macrolides and 
aminoglycosides [262, 263]. There is also evidence of some microbes also having developed 
resistance to silver [264]. 
These illustrations highlight the great need for new or alternative topical bioactive agents to 
address the shortcomings of the current ones. In our opinion, biological active components 
derived from plants are significant and important as new drugs that are likely to lead to better 
treatments for various ailments and diseases.  
3.7.1 Plant phenolics in wound dressings 
Phenolics are secondary metabolites found commonly in many foods that are integral in the 
human diet such as vegetables, fruits, grains, teas, herbs and fruits [265].  The compounds are 
classified under several groups though their commonality lies in each compound possessing a 
phenol group in its structure. One of the groups of phenolics, the polyphenols, exhibit an 
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array of valuable biological activities, including antiviral, antibacterial, antioxidant, anti-
inflammatory, and anti-carcinogenic activity [266] and have great prospects as medicinal 
products. Major emphasis has been placed on polyphenols being taken orally as dietary 
supplements. The same multiple benefits can be afforded to the skin when polyphenols are 
applied topically [267, 268] as they possess a number of properties beneficial for wound 
healing and combating a wide range of skin disorders. It is often necessary for these 
compounds to be carried in formulations or in materials to be delivered to their targets. 
Fibroin is attractive and has success as a carrier for bioactive molecules due to its chemical 
and structural properties. A wide range of molecules can thus be encapsulated and stabilized 
within the fibroin through hydrophilic and/or hydrophobic interactions [356, 357].  
SF matrices functionalized with polyphenols have provided scaffolds that are excellent 
candidates for wound healing and tissue engineering materials. Polyphenolic extracts from 
the plants Pistacia terebinthus, Pistacia lentiscus, and Hypericum empetrifolium were 
adsorbed on silk fibroin/chitosan blend films resulting in a scaffold with both antibacterial 
and antioxidant properties [269]. Kasoju & Bora prepared a curcumin releasing porous SF 
scaffold that can be used as a wound dressing or for therapy against cancerous tumours [270]. 
In addition to the inherent properties of SF, the high surface area and porosity of SF 
nanofibres make them great candidates for carrying compounds such as polyphenols. 
However, there are few reports on tissue engineering applications of SF nanofibres with 
polyphenolic compounds. Elakkiya et al. described fabrication of curcumin loaded SF 
nanofibres by coelectrospinning for drug delivery applications. The scaffold was reported to 
have high porosity (85%) and water uptake (150%) [204]. In vitro release studies showed at 
least 80% release after 10 days for formulations with up to 1.5 wt % curcumin. This report is 
based on B. mori SF and SF from African silkworm species have not been studied in this 
capacity.  
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Resveratrol (3,4',5-Trihydroxystilbene) is one of the more potent phenolics that can be found 
in grapes, berries and peanuts and red wine [271]. Resveratrol exists as two isomers; cis- and 
trans-resveratrol.  Trans-resveratrol (Figure 3.3) is the natural form of the compound and is 
more active and stable than the cis- isomer [272]. Resveratrol has been found to be active 
against several species of bacteria and dermatophytes that cause infections and a variety of 
skin conditions [273-275].  However, its applications have mostly been centred on its anti-
inflammatory and anti-cancer properties [276, 277]. For topical applications, fibroin 
promotes cell growth and proliferation but lacks other properties required for wound healing 
specific to mitigation of bacterial and pathogen growth. SF blended with polyphenolic 
compounds such as resveratrol provides a great opportunity to exploit the combined benefits 
of these natural products. As far as we could ascertain, there have been no recorded studies 
on the incorporation of resveratrol into silk nanofibres for any applications. 
 
  
 
 
 
Figure 3.3 Structure of trans-resveratrol 
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3.8 Techniques for incorporating bioactive compounds onto nanofibres 
Therapeutic compounds can be integrated into a biomaterial matrix via adsorption, covalent 
bonding to the matrix polymer, or physical entrapment or encapsulation. Encapsulation can 
be effected by co-electrospinning the compounds with the carrier polymer [278]. This 
procedure is very easy and convenient though it may result in diminished activity of the 
sensitive compounds when harsh electrospinning conditions are used. It can also be 
challenging to homogeneously mix some compounds in the polymer solution. Addition of 
some compounds can actually alter polymer solution properties, thus influencing the 
electrospinning process. For instance, the incorporation of the antibiotic cefazolin into 
poly(lactic-co-glycolic acid) (PLGA) resulted in larger nanofibre diameters as compared to 
as-spun PLGA nanofibres [279].  
It is also possible to load compounds on prefabricated nanofibres via physical adsorption or 
chemical immobilization methods. Physical adsorption is a straightforward and easy 
technique for loading bioactive molecules on nanofibrous scaffolds due to the high surface 
area to volume ratio of nanofibres. The nanofibre mat is simply placed in a solution with the 
bioactive agents or the solution poured onto the nanofibres for adsorption to occur [280]. The 
compounds bind onto the nanofibre scaffold by non-covalent interactions such as van der 
Waals forces, hydrogen bonding, or hydrophobic interactions. Introduction of bioactive 
materials in this manner often prevents degradation or loss of activity of the bioactive 
molecules [280]. The chemical immobilization method involves covalent attachment of the 
bioactive molecules onto the surface of electrospun nanofibres. The disadvantage, however, 
is that the technique may result is some partial inactivation of the immobilized molecules as 
some active sites can become chemically modified during the process [281]. 
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With co-electrospinning, solubility of the bioactive compound in the polymer will influence 
its distribution in the nanofibre scaffold as well as the drug release [282]. A rapid drug release 
profile has been observed with drugs loaded using the adsorption technique and these 
scaffolds are particular useful in early treatment [280]. In the case of chemical 
immobilization, the drugs are not as easily released from the surface of the nanofibres when 
incubated over an extended period. The drugs covalently bonded to the polymers are released 
over an extended period of time as opposed to the burst release offered by simple adsorption.   
Other factors that affect the release of drugs from nanofibre are the morphology of the fibres 
and additional interactions with the drug [283]. The concentration of the drug in the fibres 
also has an effect on the drug release kinetics. A pronounced burst has been observed with 
higher concentration, which is attributed to enrichment of the drug on the surface [283]. 
Using the above techniques, scaffolds for both local and sustained drug delivery can be 
produced depending on the compounds and polymers being used. 
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CHAPTER FOUR 
EXPERIMENTAL PROCEDURES 
4.1 Introduction 
This chapter details the materials and procedures used in the experimental work. Firstly, silk 
fibroins from different silkworm species were purified and tests were conducted to determine 
their physical and chemical properties. Fibroin based nanofibres were fabricated via 
electrospinning. Parameters affecting the electrospinning process and the properties of the 
resultant nanofibres were investigated. Resveratrol, a potent antimicrobial and antioxidant 
agent, was incorporated onto the silk nanofibre matrix via adsorption. Parameters affecting 
the loading of resveratrol onto the nanofibres were studied. Physical and biological properties 
of the resveratrol loaded silk fibroin nanofibres were then investigated.  Figure 4.1 depicts the 
experimental work and the characterizations done at the different stages of the work. 
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Figure 4.1. Block diagram showing the various stages of silk processing, parameters studied and 
characterization done in this study 
  
41 
 
4.2 Materials 
4.2.1 Reagents and Chemicals 
Unless stated otherwise, all chemical reagents used in the experiments had a purity of at least 
98 % and were purchased from Sigma Aldrich (St Louis, USA). These chemicals were used 
without any further purification. Buffers and all aqueous solutions were prepared in ultra-
high purity (UHP) water (18.2 mΩ) from a Millipore MilliQ water purification system 
(Molsheim, France). 
4.2.2 Sampling of silkworm cocoons 
Silkworm cocoons used in the study (shown in Figure 4.2) were randomly collected after the 
moths had emerged from the cocoons. Silkworm cocoons used in the study (shown in Figure 
4.2) were randomly collected after the moths had emerged from the cocoons. Gonometa 
rufobrunnae cocoons were obtained from Gwanda, Zimbabwe and from Shashe in Botswana. 
Samples of Gonometa postica cocoons were collected from Eastern Cape Province in South 
Africa. Argema mimosae cocoons were obtained from Manzini district in Swaziland. 
Additional samples of Argema mimosae, together with Epiphora bahuniae and Anaphe panda 
cocoons, were donated by Mr. Addis Teshome from the ICIPE (International Centre of Insect 
Physiology and Ecology) in Kenya.  B. mori cocoons reared in South Africa were donated by 
Elster Vermeulen.   
4.3 Processing of silk fibroin  
4.3.1 Degumming of silkworm cocoons 
Silk cocoons were treated according to their species and location. For example, Gonometa 
postica and Argema mimosae cocoons were batched  separately. Also, Gonometa 
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rufobrunnae samples from different locations i.e. from Botswana and Zimbabwe, were also 
batched separately.  
Fibroin samples were obtained by removing sericin via degumming. Briefly, cocoons were 
boiled using a two-step procedure. The cocoons were boiled in 1.1 g/L Na2CO3 for 1 h 
followed by 0.5 g/L Na2CO3 for another hour. Epiphora bahuniae and Anaphe panda 
cocoons required harsher degumming conditions firstly using 2.5 g/L Na2CO3 solution for an 
hour followed by 0.5 g/L Na2CO3 for another hour.  For B. mori cocoons, degumming was 
achieved in one step by boiling in 1.1 g/L Na2CO3 solution for an hour.  The cocoon to water 
ratio was 1:40 in the degumming procedures. After the degumming, the fibroin was 
thoroughly rinsed with warm distilled water and air dried. The fibroin (Figure 4.3) was kept 
in a cool dry cupboard until analysis. 
 
 
Figure 4.2. Samples of a) G. rufobrunnae b) G. postica c) A. panda d) A. mimosae e) E. 
bahuniae and f) B. mori silkworm cocoons used in the study 
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4.3.2 Dissolution of silk fibroin 
The effect of different salts, salt concentration and influence of organic solvents on the 
solubility of degummed silk fibroin from different species was investigated.  Commonly used 
solvent systems listed below were investigated;  
i. 9.5 M LiBr (aq) 
ii. 9.5 M LiCl (aq) 
iii. 10 M Ca(NO3)2 (aq) 
iv. Saturated CaCl2 (aq) solution 
v. LiBr:EtOH:H2O  (4:4:1) 
vi. LiCl: EtOH: H2O (4:4:1) 
vii. Ca(NO3)2:H2O:MeOH (1:4:2)  
viii. CaCl2:EtOH:H2O (1:2:8)   
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3. Degummed G. rufobrunnae silk fibres 
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 Aqueous/alcohol solvent systems were prepared by mixing the salts in water/alcohol 
mixtures according to the molar ratios indicated for each system. Dissolution of the salts was 
achieved by stirring the mixture at room temperature for about 30 min. Dissolution 
temperature of 80°C was used for the fibroins in the various solvent systems with the aid of 
magnetic stirring. Using between 10 and 20 mL of solvent, dissolution times up to 6 hours 
were studied. Fibroin was added to the solvents in 1 % increments starting from 0.5 % w/v 
concentrations. The point at which fibroin could no longer be dissolved in the solutions was 
noted as the maximum dissolution concentration. Undissolved material was removed by 
centrifugation and filtration to obtain clear brown fibroin solutions (Figure 4.4).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.4. Dissolved Gonometa rufobrunnae and Gonometa postica silk fibroin 
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4.3.3 Preparation of Regenerated Silk Fibroin (RSF) 
Dialysis is an important step by which the salts used in the dissolution process are removed 
from the silk solution. Silk fibroin (SF) solutions were dialyzed for three days against UHP 
using Snakeskin dialysis tubing with a molecular weight cut-off of  3,500 Da (Thermo 
Scientific, Illinois, USA). The resultant aqueous fibroin solutions (Figure 4.5) were frozen at 
-20 °C for at least 24 h. RSF powders were prepared by either freeze drying or via rotary 
evaporation.  For freeze drying, samples were placed in a freezer (-80 °C) for 1 h to ensure 
they were completely frozen before freeze drying at -80 °C for 3 days. For rotary 
evaporation, the frozen RSF solutions were thawed and the water layer was decanted leaving 
behind the fibroin. The fibroin was then immersed in neat methanol for 5 min prior to drying 
using a rotary evaporator at room temperature. The RSF powders obtained from both 
methods were stored in a dessicator until use. 
 
Figure 4.5. Dialyzed Gonometa rufobrunnae and Gonometa postica silk fibroin solutions 
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4.4 Preparation of silk fibroin nanofibres  
4.4.1 Electrospinning parameters 
SF nanofibres were prepared using Gonometa fibroin via electrospinning. The 
electrospinning setup included a power supply, syringe pump, syringe with needle tip and the 
aluminium foil collector (Figure 4.6).   
Water, formic acid (FA) and trifluoroacetic acid (TFA) were studied as electrospinning 
solvents. The electrospinning solutions were prepared by dissolving FD-RSF or RD-RSF 
powders in the solvent under constant stirring at room temperature until a homogeneous 
solution was obtained. Each RSF solution was electrospun at ambient temperature through a 
gauge 20 stainless steel needle fitted on a 3 mL disposable syringe at a flow rate controlled 
by a syringe pump (New Era, NE 1000). RSF concentrations of 10-40 % (w/v) were 
investigated. Applied voltages from 10-25 kV and flow rates between 0.05-0.80 mL min 
-1
 
were studied. Tip to collector distance was varied from 7 to 20 cm.  
4.4.2 Post treatment of silk fibroin matrices 
Methanol, ethanol, propanol, acetone and chloroform were used to assess solvent-induced β-
sheet crystallization of fibroin. Electrospun nanofibres were immersed in each of the above 
mentioned solvents for 15 min. Nanofibres were also treated with water vapour by placing 
them in a desiccator containing saturated sodium sulphate decahydrate solution for 16 h. The 
nanofibres were then vacuum dried in a dessicator at room temperature for 24 h prior to 
analysis.  
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Figure 4.6. Equipment and setup used for electrospinning 
 
4.5 Adsorption and release of resveratrol on silk nanofibres 
4.5.1  Adsorption studies 
Resveratrol solutions (10-50 ppm) used for the adsorption studies were freshly prepared by 
dissolving resveratrol in ethanol. Fibroin nanofibre samples (6-8 mg) were immersed in 5 mL 
of the resveratrol solutions. The resveratrol uptake of the nanofibres was determined by 
measuring the change in solution concentration after immersion. Aliquots of 70 µL were 
drawn at different time intervals between 0-2 h to determine rate of adsorption. The 
resveratrol was measured using an Agilent 7100 capillary electrophoresis system 
(Waldbronn, Germany) with a diode array detector (DAD) (Figure 4.7). 30 mM phosphate 
buffer at pH 8.0 was used for the separation and detection was at 285 nm. The influence of 
time, temperature, initial resveratrol concentration and shaking on the adsorption of 
Power supply 
Syringe  
Syringe pump 
Collector 
Needle  
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resveratrol onto the silk nanofibres was examined. The resveratrol loaded nanofibres were 
dried under vacuum and stored in a dark cupboard until further analysis. 
4.5.2  Release studies 
For the release studies, the resveratrol loaded nanofibres were incubated in tubes containing 5 
mL of phosphate buffered saline (PBS) at pH 7.4. The suspensions were gently shaken in a 
thermostated water bath maintained at 37 ºC. Samples of 100 µL released solution were taken 
at predetermined intervals and the same amount of fresh PBS solution was added to replace 
the extracted aliquot. The extracted aliquot was then dried using a rotavapor and reconstituted 
in ethanol. A standard addition method was used to quantify the released resveratrol.  
  
4.6  Characterization studies 
4.6.1  Micellar electrokinetic chromatographic (MEKC) analysis of fibroin 
4.6.1.1   Instrumentation 
An Agilent 7100 capillary electrophoresis system equipped with a DAD detector was used 
for separation and quantification of amino acids (Figure 4.7). The optimum wavelength for 
detection was 210 nm. Instrument control, data collection and processing were achieved 
using Agilent Chemstation revision B.04.01 (DE, Germany).  
Uncoated fused silica capillaries (Agilent, Germany) with 50 µm id, 63.5 cm total length and 
55.0 cm effective length were used. Buffer pH was adjusted using a Metrohm 827 pH meter 
(Hersau, Switzerland) 
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4.6.1.2  Separation conditions 
Buffers used for the study were prepared by weighing out the appropriate amounts of each 
component and dissolving in UHP water. A MEKC separation was developed using the 
surfactant SDS in phosphate and borate buffers. Influence of pH, temperature and applied 
voltage on the separation was investigated. All new capillaries were conditioned by rinsing 
with methanol for 5 min, followed by a 10 min rinse with 1 M NaOH and ultra-high purity 
water respectively. The capillaries were then conditioned with the running buffer. To ensure 
reproducible migration times and peak areas, capillaries were rinsed between runs with buffer 
for 15 min. The capillary was rinsed with water for 10 min at the end of each working day. 
Samples were pressure injected at 50 mbar for 2 sec.  
Figure 4.7. Agilent 7100 Capillary electrophoresis system used in the study 
  
50 
 
All rinsing solutions, background electrolytes and samples were filtered through 0.45 µm 
PVDF filters. Buffers were stored at 4 °C and the pH checked regularly throughout the 
experiments. 
4.6.1.3  Hydrolysis of fibroin  
For each silkworm species, five replicates of 5 mg of fibroin were accurately weighed into 
acid-washed reaction vials. One mL of 6 M HCl was added to each vial and thoroughly 
mixed using a vortex mixer. The vials were deaerated by purging with nitrogen for about two 
minutes and were immediately tightly capped. Hydrolysis was carried out in an oven at 110 
°C for 24 h after which the hydrolysates were cooled to room temperature. Hydrolysates were 
then filtered through a 0.45 µm PVDF membrane filter to remove any solid impurities.  
4.6.1.4  Preparation of calibration standards 
The calibration curve was prepared using six concentration levels of amino acid standards 
covering a concentration range of 0.005 mg mL
-1
 to 0.05 mg mL
-1
. These calibration 
standards were prepared from a stock solution of 0.1 mg mL
-1
 prepared by dissolving amino 
acids in UHP water and a few drops of 0.1 M NaOH added to facilitate dissolution.  
4.6.1.5  Derivatization of amino acids with phenylisothiocyanate (PITC) 
Derivatization was done for detection of the amino acids using UV detection. The reagent 
phenylisothiocyanate (PITC) used in the study reacts with free amino acids under basic 
conditions to produce phenylthiocarbamyl (PTC) amino acid derivatives [284] as shown in 
Figure 4.8.  
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An appropriate volume of the calibration standard solution for each concentration level was 
pipetted into a vial and dried under vacuum for 30-60 min. 20 µL of re-drying solution which 
consisted of methanol:water:triethylamine (2:2:1, v/v/v), was added to each vial and then 
dried under vacuum for 30 min. Derivatization then proceeded by adding 30 µL of the 
derivatizing reagent consisting of methanol:water:triethylamine:PITC (7:1:1:1, v/v/v/v) to 
each vial. After vortexing for 30 sec, the vials were tightly closed and incubated at room 
temperature for 30 min. The amino acid-phenylthiocarbamyl (PTC) derivatives were then 
dried in vacuo using a SpeedVac (Thermo Fisher, USA). Fibroin samples were derivatized 
according to the procedure described above except that 50 µL aliquots of sample and 100 µL 
of reagents were used at each stage. The re-drying process was done twice for the samples. 
PTC-amino acids were stored at -20 °C and were re-constituted in the running buffer just 
before analysis. 
 4.6.2 Validation procedures 
The MEKC method was validated for linearity, limit of detection (LOD), limit of 
quantification (LOQ), recovery and precision. Precision was evaluated by assessing injection 
Figure 4.8. Derivatization reaction of PITC with amino acids  
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and method repeatability (intra-day repeatability) as well as intermediate precision (inter day 
precision). Statistical evaluation parameters were calculated using the data analysis tool in 
Microsoft Excel. 
4.6.3 Scanning Electron Microscopy 
Undegummed, degummed and electrospun nanofibres were examined using scanning 
electron microscopy (SEM).  Images were obtained using a TESCAN Vega VG1760481J 
scanning electron microscope (Brno, Czech Republic). Nanofibre samples were prepared by 
cutting an aluminium sheet covered with electrospun fibres and fixing it onto the copper stubs 
used in the analysis. Degummed and undegummed fibres were fixed onto the copper stubs 
using adherent tape. Each specimen was gold-coated prior to analysis at 20 kV. Diameters of 
the electrospun fibres were also estimated by randomly measuring 25 fibres from different 
SEM images.  
4.6.4 FTIR spectroscopy 
Fourier transform infrared (FTIR) spectra for the degummed and undegummed silk fibres 
were obtained from a Perkin Elmer spectrometer (Massachusetts, USA) with an ATR 
attachment spectrometer. Spectra were acquired in transmittance mode with 32 scans at a 
resolution of 2 cm
-1
 over the 4000-600 cm
-1
 spectral region. FTIR analysis for the RSF 
powders and nanofibres was done using a Perkin Elmer RX1 spectrometer (Massachusetts, 
USA) with a Miracle
TM
 ATR attachment. Spectra were acquired in transmittance mode with 
32 scans at a resolution of 2 cm
-1
 over the 4000-600 cm
-1
 spectral region. 
4.6.5  FT-Raman spectroscopy 
The morphology of silk fibres was examined using a Bruker MultiRAM FT-Raman 
spectrometer (Ettlingen, Germany) with a germanium detector. Silk samples were mounted 
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vertically in front of a mirror and the spectra were accumulated from 512 scans at a 4 cm
-1
 
resolution using 0.45 W laser power. 
4.6.6 X-ray diffraction 
Diffraction curves were recorded using a PANalytical X’pert Pro X-ray diffractometer 
(Almelo, Netherlands) with Cu (Kα) radiation (λ = 1.54 Å) from 1° to 70° with a scan step 
size 0.02626° (2θ). Voltage and current of the X-ray source were 45 kV and 40 mA, 
respectively.  
4.6.7 Thermal Analysis  
Thermogravimetric analysis (TGA) of the silk fibres and nanofibres were studied using a TA 
Instruments TGA Q500 (DE, USA). Samples (10-15 mg) were loaded into a platinum 
crucible. The samples were heated under nitrogen from 25 to 1000 °C at a heating rate of 10 
°C min
−1
.  
For differential scanning calorimetry (DSC), a TA Instruments DSC Q2000 ( DE,  USA) 
calorimeter was used with a scanning rate of 10 °C min
−1
 (between 25 and 450 °C) and 
nitrogen and air gas flow rate of 50 mL min
−1
. Approximately 4.5 mg samples were used for 
the analysis. 
4.6.8 Mechanical properties 
The silk fibres were kept in the lab under atmospheric condition of 20 ± 1 °C and relative 
humidity of 65 ± 2% for at least 24 h before testing. The conditioned samples were then 
tested for bundle strength, tenacity and fibre fineness. The fibres were carefully combed with 
a fine comb, and then fibre bundles were prepared. The bundle tensile test was carried out on 
the Instron Tensile Tester (Model 4411) at 0.01 mm gauge length using the Pressley method 
(ASTM 3060:1974). Ten bundles were tested per sample with bundles being carefully 
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assembled to ensure continuous and parallel fibres in the test area. The bundles were weighed 
and the linear density (Tex) of the fibre bundles was calculated using a gravimetric method. 
The fibre diameter was estimated by measurement of mean fibre diameter per sample using 
an Optical Fibre Diameter Analyser (OFDA). The cross-section of one sample was examined 
with Image analyser (Olympus CX31 Image analyser) at 400X magnification.  
4.6.9 Degradability  
The mass loss of the nanofibres, following immersion in water and PBS at pH 7.4 for 24 h, 
was measured. Degradability was calculated as a percentage by comparing the mass of the 
nanofibres before and after immersion. 
4.6.10 Cytotoxicity studies 
The cytotoxic effects of the nanofibres were tested by Sulforhodamine B (SRB) assay on the 
WI38 cell line. The WI-38 cell line - normal Human Fetal Lung Fibroblast from ECACC was 
routinely maintained as a monolayer cell culture at 37 ºC, 5% CO2, 95% air and 100% 
relative humidity in EMEM containing 10% fetal bovine serum, 2 mM L-glutamine and 50 
µg/ml gentamicin.   
  For screening experiments, the cells (21-50 passages) were inoculated in 96-well microtiter 
plates at plating densities of 10 000 cells/well and were incubated for 24 h. After 24 h the 
cells were treated with different masses of the samples in DMSO. Cells without addition of 
samples served as control. The blank contained complete medium without cells. Etoposide 
was used as a standard.  The plates were incubated for 48 h after addition of the samples. 
Viable cells were fixed to the bottom of each well with cold 50% trichloroacetic acid, 
washed, dried and dyed by SRB. Unbound dye was removed and protein-bound dye was 
extracted with 10 mM Tris base for optical density determination at the wavelength 540 nm 
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using a multiwell spectrophotometer. Data analysis was performed using GraphPad Prism 
software. 50% of cell growth inhibition (IC50) was determined by non-linear regression. 
4.6.11  Antibacterial activity  
The antibacterial properties of the nanofibres were tested using the disc diffusion method. 
Gram negative Escherichia coli (E. coli) and gram positive Staphylococcus aureus (S. 
aureus) bacteria were used for the tests. The tests were carried out for resveratrol solutions at 
different concentrations and on SF nanofibres with and without resveratrol. The resveratrol 
solutions (2 µL) were impregnated into sterile filter paper discs. The resveratrol-paper discs 
samples and nanofibre samples were applied to the surface of the agar plate containing the 
microorganism to be tested. The effectiveness of the samples against the studied bacteria was 
assessed by the growth inhibition zones. The zones of inhibition are observed as clear areas 
surrounding the disc due to the diffusion of the antimicrobials into the plate.  
4.6.12  Antioxidant activity 
The radical scavenging activity was determined using DPPH (2,2-diphenyl-1 -picrylhydrazyl 
hydrate) assay. Briefly, the stable free radical DPPH was dissolved in methanol to give a 100 
μM solution. Different masses of the nanofibre samples were immersed in DMSO in 96 well 
plates and then treated with DPPH solution. The mixtures were shaken vigorously and kept in 
the dark for 30 min at room temperature. Change in absorbance was measured 
spectrophotometrically at 540 nm.  Each concentration of nanofibre samples was assayed in 
triplicate wells. DPPH + DMSO without addition of sample served as control. The blank 
contained methanol + DMSO and gallic acid was used as a standard. Radical scavenging 
activity was calculated by the following formula: 
           % Radical scavenging = [(A DPPHControl - ADPPHTest)/ A DPPHControl] × 100 
  
56 
 
4.6.13  Anticancer activity 
The growth inhibitory effects of the samples were tested in the 3-cell line panel consisting of 
TK10 (renal), UACC62 (melanoma) and MCF7 (breast) cancer cells by Sulforhodamine B 
(SRB) assay. The human cell lines TK10, UACC62 and MCF7 was obtained from the Drug 
Evaluation Branch (NCI) in the framework a collaborative research program between the 
Council of Science and Industrial Research (CSIR) and NCI. Cell lines were routinely 
maintained as a monolayer cell culture at 37 ºC, 5% CO2, 95% air and 100% relative 
humidity in RPMI containing 5% fetal bovine serum, 2 mM L-glutamine and 50 µg/ml 
gentamicin.   
For the screening experiment, cells (3-19 passages) were inoculated in 96-well microtiter 
plates at plating densities of 7-10 000 cells/well and were incubated for 24 h. After 24 h, one 
plate was fixed with TCA to represent a measurement of the cell population for each cell line 
at the time of sample addition (T0). The other plates with cells were treated with different 
masses of the nanofibres in DMSO. Cells without the nanofibres served as control. The blank 
contained medium without cells. Etoposide was used as a reference standard. The plates were 
then incubated for 48 h after addition of the nanofibres. Viable cells were fixed to the bottom 
of each well with cold 50% trichloroacetic acid, washed, dried and dyed by SRB. Unbound 
dye was removed and protein-bound dye was extracted with 10 mM Tris base for optical 
density determination at the wavelength 540 nm using a multiwell spectrophotometer. Optical 
density measurements were used to calculate the net percentage cell growth. 
 
 
 
  
57 
 
CHAPTER FIVE 
CHEMICAL AND PHYSICAL PROPERTIES OF SILK FIBROIN 
5.1  Introduction 
This chapter presents results on the chemical and physical characteristics of the studied 
African silk fibroins. Comparison was done with B. mori fibroin because of its extensive use 
as a model for investigating and correlating the chemical and physical properties of silk 
proteins. Reference to other wild silkworm species is made where appropriate. Part of this 
work has been published in International Journal of Biological Macromolecules [71].  
5.2  Development of MEKC separation for PTC-modified amino acids 
Our previous study focused on developing a MEKC method with borate and/or phosphate 
buffers using the anionic sodium dodecyl sulphate (SDS) as a surfactant. The best separation 
achieved baseline resolution of thirteen amino acids in sericin derived from Gonometa 
rufrobrunnae [285]. The current work aimed to improve the previous method with an attempt 
to resolve all eighteen amino acids found in silk fibroin.  Parameters evaluated were those 
that play a critical role in MEKC separations such as concentration of SDS, buffer type, 
concentration and pH.  
It should be noted peak identification was not done during the preliminary method 
development studies (Figures 5.1 and 5.2). The detail of peak identity is therefore given when 
the best separating conditions using for the borate-SDS and phosphate-SDS buffers were 
used. 
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5.2.1 MEKC with borate buffer 
When developing a MEKC separation, optimization of separation of components in CZE 
mode is often the starting point. Using borate, 20 mM buffer at pH 9.0 showed improved 
resolution of the amino acids (Fig 5.1a) with 14 peaks observed compared to the 11 peaks 
seen using 10 mM borate (Fig 5.1b). Further increase in the borate concentration did not yield 
better results; therefore this 20 mM concentration was used in developing the MEKC method.  
The concentration of SDS was varied from 20 mM to 120 mM in the 20 mM borate buffer at 
pH 9.0. The critical micelle concentration (CMC), which is the minimum concentration 
above which micelles are formed, of SDS is around 8 mM  and varies with presence of 
different additives such as organic solvents and salts [286]. Concentrations above 10mM 
were therefore investigated. There was no significant improvement in separation when 20 
mM concentration of SDS was added to the running buffer (results not shown). However, as 
the SDS concentration was increased, significant improvement in separation of the analytes 
was observed. 
Figure 5.2 shows electropherograms where 20 mM/60 mM borate-SDS and 20 mM/100 mM 
borate-SDS buffers both at pH 9.0 were used. In both systems, 17 peaks were separated, 
although using 20 mM/100 mM borate-SDS buffer resulted in better resolution with a total of 
9 being baseline resolved as compared to 7 with 20 mM/60 mM borate-SDS buffer. 
Increasing the SDS concentration resulted in increased partitioning of the amino acids 
between the buffer and the pseudo-stationary phase thereby improving resolution. Higher 
SDS concentrations also result in longer run times as micelles tend to move slowly towards 
the detector because of their counter mobility towards the anode. Increasing the SDS 
concentration resulted in increased partitioning of the amino acids between the buffer and the 
pseudo-stationary phase thereby improving resolution. Higher SDS concentrations also result 
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in longer run times as micelles tend to move slowly towards the detector because of their 
counter mobility towards the anode. Also, with more micelles, there are additional 
chromatographic interactions between the pseudo-stationary phase and the analytes which 
also contributes to longer run times. 
Figure 5.1. CZE of 20 PTC-amino acids using a) 10 mM borate buffer, pH 9.0 and b) 20 mM 
borate buffer, pH 9.0. Conditions: Capillary, 40 cm effective length (total 48.5 cm) x 50 µm i.d; 
voltage +20 kV, pressure injection (50 mb for 2 sec); temperature 25 °C; UV-Vis detection at 210 nm 
(peaks not identified)  
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Figure 5.2. MEKC of 20 PTC-amino acids using a) 20 mM/60 mM borate SDS buffer pH 9.0 and 
b) 20 mM/100 mM borate SDS buffer pH 9.0. Conditions: as in Figure 5.1 (peaks not identified) 
 
Better separation was achieved using 20 mM/120 mM borate SDS buffer (Figure 5.3). Under 
these conditions, 19 peaks were observed with 14 being baseline resolved. Of the resolved 
peaks, 11 were identified as amino acids and the remaining ones, including the largest peak 
around 34.9 min, were due to excess PITC reagent and its by-products. 
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Figure 5.3. MEKC of PTC-amino acids using 20 mM/120 mM borate SDS buffer, pH 9.0. 
Conditions: as in Figure 5.1  
 
Coelution was observed for some amino acids which can be correlated to their properties. For 
example, the coeluting pairs of valine + alanine have similar pKa values (see Table 2.4) and 
therefore close isoelectric values (5.96 and 6.00 respectively). In addition they have similar 
structures that do not interact much with SDS micelles hence they present a challenge to 
separate. Higher concentrations of SDS did not afford any significant improvement in 
resolving coeluting peaks and had a significant increase  in run times (>50 min). Since no 
further improvement could be realized with borate buffer, MEKC using phosphate buffer 
system was investigated.  
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5.2.2  MEKC with phosphate buffer 
Phosphate buffer provides an alternative operating pH range from borate buffer thereby 
manipulating the electrical charge on the different analytes. It therefore offers different 
separation conditions for the amino acids. Conditions for the phosphate–SDS buffer system 
were adapted from Zahou et al. [287] and optimized to achieve the best separation for 
quantification of the amino acids. In their study, resolution of 18 amino acids was achieved 
within 15 min using 29 mM phosphate buffer (pH 7.4) containing 168.3 mM SDS. In this 
study, separation for most of the amino acids was achieved using a 32 mM phosphate buffer 
with 172 mM SDS at pH 6.70 where 17 PTC-amino acid derivatives were baseline resolved 
with the exception of cystine (Cys) and the internal standard norleucine (Nleu) which were 
not included in those analyzed by Zahou et al.  
In previous work [285], mixed buffer systems have been found to improve resolution of some 
coeluting amino acids.  Incorporation of 0.5 mM concentration of borate into the phosphate-
SDS buffer improved the resolution between Cys and Nleu. Resolution of the 19 amino acid 
standards was thus achieved within 20 min using an optimum buffer system consisting of 32 
mM/0.5 mM phosphate-borate buffer at pH 6.70 with 172 mM using an applied voltage of 
+26 kV. The optimum temperature for the separation was 27 °C where the resolution of 
closely co-eluting tyrosine and alanine as well as glycine and valine was also improved 
(Figure 5.4).  
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Figure 5.4. MEKC of  PTC-amino acids at 0.005 mg mL
-1
 concentration using 32 mM phosphate 
/0.5 mM borate /172 mM SDS buffer, pH 6.70. Conditions:  Capillary, 55 cm effective length (total 
63.5 cm) x 50 µm i.d; voltage +26 kV, temperature 27 °C; UV-Vis detection at 210 nm. Peak i.d: 1 = 
proline, 2 = threonine, 3 = serine, 4 = tyrosine, 5 = alanine, 6 = glycine, 7 = valine, 8 = methionine, 9 
= histidine, 10 = isoleucine, 11 = leucine, 12 = cysteine, 13 = phenylalanine, 14 = tryptophan, 15 = 
glutamic acid, 16 = lysine, 17 = aspartic acid, 18 = arganine, IS = internal standard (norleucine) 
 
5.3 Method Validation 
5.3.1. Linearity  
An external standard calibration approach was used for quantitation of the amino acids. Six 
concentration levels with five replicates were used to determine linearity. Detector responses 
of the amino acid analytes were normalized against the response of the internal standard Nleu 
to give peak area ratios or corrected peak area ratios. Corrected peak areas (peak area of 
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analyte divided by migration time of the analyte) are often used in CE to compensate for 
differential migration of analytes through the detector as well as migration time drifts thereby 
minimizing quantitative bias [288]. Calibration curves plotted using both uncorrected peak 
area ratios and corrected peak area ratios showed significant linearity (Table 5.1). The 
linearity was assessed using the F-test at 95% confidence level where large F values indicate 
significant linearity of the calibration curve when using ANOVA. Better correlation 
coefficients (0.9979 to 0.9999) were obtained using corrected peak areas as compared to 
those with uncorrected peak areas (0.9850 to 0.9997). Therefore, calibration curves used for 
quantification purposes were plotted using corrected peak area ratios.  The significance of the 
error of regression was evaluated using the F-test where the standard deviation of ten 
replicate samples was compared to the standard error of regression of the calibration curve 
for the analyte. Calculated values indicated that the regression residuals observed are 
attributable to random error rather than systematic error at 95% confidence level. Overall, our 
calibration curves could be used to reliably quantify the analytes of interest. 
5.3.2 Limit of Detection (LOD) and Limit of Quantification (LOQ) 
In this study no suitable blank was available for determination of limit of detection and limit 
of quantification. Both the LOD and LOQ of the method were therefore determined from 
regression statistical analysis according to ISO11843 method. The parameters were 
calculated as follows: 
𝐿𝑂𝐷 =
3𝑠𝑦/𝑥
b
 and  𝐿𝑂𝑄 =
10𝑠𝑦/𝑥
b
 
where sy/x is the standard error of regression and b is the slope of the curve. The values 
obtained were in the range of 0.6-5.1 mg L
-1
 and 2.0-17.1 mg L
-1
 for LOD and LOQ 
respectively (Table 5.2). 
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5.3.3. Precision 
Intra-day and inter-day variability was measured to assess precision and all results are shown 
in Table 5.2. Injection repeatability was assessed by injecting one standard (0.04 mg mL 
-1
) 
ten times and calculating RSDs of corrected peak area ratios and migration times. Injection 
repeatability RSDs values averaged 0.83 % and 3.16 % for migration time and peak area 
respectively. For method repeatability ten replicate standards at 0.03 mg mL
-1
 were analyzed 
and RSDs of peak area and migration time were calculated.  Maximum values obtained were 
2.8 % and 6.3 % for migration time and peak area respectively. 
Intermediate precision was done by injecting standards at 0.01, 0.02 and 0.04 mg mL 
-1 
on 
different days over a period of three weeks. RSD values observed at the three concentration 
levels were less than 3.2 % and 8.2 % for migration time and peak area respectively. 
Generally, RSD values were larger for the slow migrating analytes compared to the fast 
migrating ones. Precision results showed that MEKC method has good repeatability and is 
reliable for quantification of the analytes of interest. 
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Table 5.1. Linearity, regression, LOD, LOQ data for of PTC- amino acids using the developed MEKC method 
 
 
a
F statistic value from F-test using ANOVA 
b 
Sy/x represents standard error of regression 
Peak 
number 
Amino acid Correlation coefficients, r 
a
F value  
  Uncorrected 
peak area 
Corrected 
peak area 
Uncorrected 
peak area 
Corrected 
peak area 
intercept slope  LOD 
mgL
-1
 
LOQ 
mg L
-1 
b
Sy/x 
1 Proline 0.9994 0.9999 4886 44428 0.355  1.36  0.7 2.2 0.3 
2 Threonine 0.9997 0.9999 8364 45139 0.285  1.17  0.8 2.2 0.3 
3 Serine 0.9989 0.9997 2401 10485 0.743  1.20  1.3 4.5 0.5 
4 Tyrosine 0.9994 0.9998 4183 14225 0.599  1.10  1.2 3.8 0.4 
5 Alanine 0.999 0.9999 12235 42367 0.328  1.70  0.7 2.2 0.4 
6 Glycine 0.9994 0.9999 4249 53877 -0.117 2.04  0.6 2.0 0.4 
7 Valine 0.9997 0.9998 8359 13030 0.495  1.25  1.2 4.0 0.5 
8 Methionine 0.9991 0.9997 3035 8965 0.427  1.20  1.5 4.8 0.6 
9 Histidine 0.9986 0.9998 1722 12596 -0.102  1.38  1.2 4.1 0.6 
10 Isoleucine 0.9984 0.9996 1659 7016 -0.018  1.23  1.6 5.5 0.7 
11 Leucine 0.9989 0.9999 2408 41729 -0.012  1.22  0.7 2.2 0.3 
12 Cysteine 0.9997 0.9997 7384 10327 0.142  1.29  1.6 5.3 0.7 
13 Phenylalanine 0.9940 0.9979 412 1204 -0.584  1.51  2.0 6.6 2.0 
14 Tryptophan 0.9850 0.9998 257 13779 0.142  1.95  0.9 2.9 0.6 
15 Glutamic acid 0.9987 0.9999 2001 32919 -0.053  0.925  0.8 2.5 0.2 
16 Lysine 0.9924 0.9979 329 1199 -3.53  2.47  4.0 13.2 2.3 
17 Aspartic acid 0.9993 0.9996 3707 6594 0.048  0.961  2.3 7.5 0.7 
18 Arginine 0.9965 0.9991 716 2182 2.120  0.926  5.1 17.1 1.6 
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Table 5.2. Intra and inter-day precision data for PTC-amino acids using the developed MEKC method 
 
Amino acid Injection repeatability (intra-
day) 
n=10 
 
Method repeatability (intra-day) 
n=10 
 
 
Inter day repeatability 
n=7 
 
 
0.01 mg  mL
-1
 0.02 mg  mL
-1
 0.04 mg  mL
-1
 
Migration time 
(min), RSD 
(%) 
 
Corrected 
peak area, 
RSD (%) 
 
Migration time 
(min), RSD (%) 
 
Corrected peak 
area, RSD (%) 
 
Migration 
time (min), 
RSD (%) 
 
Corrected 
peak area, 
RSD (%) 
 
Migration 
time 
(min), 
RSD (%) 
Corrected 
peak area, 
RSD (%) 
 
Migration 
time (min), 
RSD (%) 
Corrected 
peak area, 
RSD (%) 
 
Proline 0.6 3.3 1.0 4.4 1.6 6.8 1.6 3.6 1.2 2.7 
Threonine 0.7 3.8 1.1 4.0 1.6 5.7 1.7 3.7 1.5 4.4 
Serine 0.7 2.4 1.0 3.9 1.6 4.5 2.1 4.4 2.6 3.5 
Tyrosine 0.7 1.9 1.1 4.4 1.7 4.4 1.9 4.0 1.8 6.1 
Alanine 0.7 2.7 1.1 3.0 1.7 3.6 1.5 3.0 1.9 3.7 
Glycine 0.7 3.0 0.7 3.1 1.7 3.3 1.8 4.1 2.5 5.4 
Valine 0.7 3.6 1.2 4.4 1.6 7.1 1.8 5.3 1.4 3.7 
Methionine 0.7 4.3 1.2 3.2 1.8 5.7 1.7 5.4 1.4 3.6 
Histidine 0.8 3.2 1.5 4.2 2.0  4.2 1.8  4.6 1.7 3.2 
Isoleucine 0.7 1.7 1.4 3.3 1.8 2.2 2.1 3.0 2.7 4.7 
Leucine 0.7 3.0 1.5 5.5 1.8 5.9 2.3 4.5 2.8 5.0 
Cysteine 0.7 3.3 1.6 3.8 2.1 6.1 2.3 6.5 1.9 3.5 
Phenylalanine 0.8 2.5 2.0 4.6 2.0 6.3 2.4 5.1 1.9 3.2 
Tryptophan 1.0 2.8 1.9 5.5 2.3 7.3 2.7 3.9 2.3 2.0 
Glutamic acid 1.1 4.2 1.6 4.5 2.2 4.2 2.5 6.3 2.4 4.6 
Lysine 1.0 3.4 2.0 5.8 2.2 7.5 2.9 7.2 3.1 5.3 
Aspartic acid 1.3 3.2 2.0 5.8 1.8 4.2 2.1 4.2 2.8 3.7 
Arginine 1.5 4.6 2.8 6.3 2.5 6.9 3.1 8.2 2.9 7.4 
Average 0.8 3.2 1.5 4.4 1.9 5.4 2.1 4.8 2.2 4.2 
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5.4 Quantification of amino acids in fibroin samples 
The validated method was applied for the separation and quantification of amino acids in 
fibroin samples from the silkworm species (Figure 5.5). Some of the peaks in the 
electrophoregram exhibited tailing, possibly due to sample matrix effects which cause 
changes in ionic strength of the injected sample plug and the running buffer. The unidentified 
peaks seen in the electrophoregrams are by- products of PITC as determined during the 
method development. The mass of amino acids recovered as a ratio of total mass of fibroin 
hydrolyzed was 70-80 % for all species analyzed. Acid hydrolysis can be a major contributor 
to variation of amino acid quantification due to complete or partial destruction of some amino 
acids. Some reports indicate that serine, threonine and methionine can be partially destroyed 
during hydrolysis. Tryptophan is completely destroyed during the process therefore only 
seventeen of the reported eighteen amino acids were identified and quantified in the studied 
SF. It has also been reported that some peptide linkages, particularly those between amino 
acids possessing bulky side chains such as Ile-Ile, Val-Val, Ile-Val, Val-Ile, undergo slow 
and/or incomplete hydrolysis due to steric hindrance [289]. The side chains of asparagine and 
glutamine are deaminated resulting in aspartic and glutamic acid. Therefore the % quantity 
reported for the acids is inclusive of the amides that may be present in the fibroin.  
Table 5.3 shows the quantification and precision data for amino acids in fibroin protein from 
the species investigated. Repeatability of peak areas was generally better for amino acids 
present at higher concentrations in the fibroin such as glycine and alanine than for those 
present in low concentrations such as methionine, cysteine and isoleucine. Consistent with 
reports from other studies, the fibroins were mostly composed of glycine, alanine, and serine, 
which amounted to at least 70% in all the species studied. These three amino acids are the 
main components of the characteristic primary structure which makes up the β-sheet structure 
in the crystalline region of fibroin [290, 291]. Their nonpolar nature therefore renders fibroin 
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mainly hydrophobic. A. panda had the highest composition of these three amino acids with 
glycine and alanine alone contributing almost 85 % of the total amino acids. In contrast, 
Kebede et al. reported glycine and alanine of A. panda amounted to only 62 % [72]. Their 
study however only reported a few of the amino acids found in fibroin. Our results are 
however very similar to those reported for other Anaphe silks [292]. 
 
 
Figure 5.5. MEKC separation of amino acids in a) G. postica and b) A. mimosae silk fibroin 
hydrolysates using 32 mM phosphate /0.5 mM borate /172 mM SDS buffer, pH 6.70. Conditions and 
peak i.d as in Figure 5.4
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Table 5.3A. Amino acid composition of fibroin protein from the silkworm species as determined by the developed MEKC method 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a
LC, long chain amino acids and SC, short chain amino acids. 
n=5 G. rufobrunnae (Botswana) 
% ± SD              RSD 
G. rufobrunnae (Zimbabwe) 
% ± SD                 RSD 
A. mimosae (Kenya) 
% ± SD                    RSD 
A. mimosae (Swaziland) 
% ± SD              RSD 
Non-polar   
Glycine 33.2 ± 1.5 4.0 35.1 ± 1.7 4.8 24.4 ± 1.9 3.9 23.9 ± 1.6 4.1 
Alanine 26.0 ± 1.5 4.3 28.4 ± 1.3 5.1 36.1 ± 1.2 4.7 36.4 ± 1.6 4.3 
Proline  2.3 ± 0.2 7.7 2.4 ± 0.2 6.3 0.2 ± 0.1 11.8 0.4 ± 0.1 12.5 
 Valine 1.4 ± 0.2 9.1 1.6 ± 0.1 8.1 0.8 ± 0.1 12.3 0.7 ± 0.1 11.7 
Leucine 1.2 ± 0.2 8.4 1.4 ± 0.2 7.7 5.5 ± 0.4 5.9 6.2 ± 0.3 5.1 
Isoleucine 0.7 ± 0.1 13.7 0.8 ± 0.1 13.1 0.2  19.7 0.2  19.3 
Methionine 0.3 ± 0.1 18.2 0.3 ± 0.1 17.1 -  -  
Polar   
Serine 13.1 ± 0.5 4.6 13.4 ± 0.4 5.4 10.4 ± 0.4 4.9 10.1 ± 0.3 6.1 
Threonine 0.7 ± 0.1 11.4 0.8 ± 0.1 11.9 0.3 ± 0.1 14.7 0.4 ± 0.1 14.0 
Cysteine 0.1 18.9 0.1 19.2 detected  detected  
Acidic  
Aspartic acid 3.0 ± 0.1 6.8 2.6 ± 0.1 8.7 4.0 ± 0.2 7.1 3.8 ± 0.2 7.7 
Glutamic acid 1.1 ± 0.1 9.0 0.9 ± 0.1 9.4 1.4 ± 0.2 9.5 1.0 ± 0.2 10.1 
Basic  
Arganine 6.5 ± 0.2 4.6 5.4 ± 0.2 5.0 4.8 ± 0.2 17.1 5.1 ± 0.2 17.1 
Lysine 0.9 ± 0.1 8.9 1.0 ± 0.1 10.1 1.0 ± 0.2 12.2 0.8 ± 0.1 12.2 
Histidine 0.3  16.1 0.3 ± 0.1 14.9 0.2 ± 0.1 18.3 0.3 ± 0.1 18.3 
Aromatic  
Tyrosine 9.1 ± 0.4 6.7 10.9 ± 0.5 5.3 6.8 ± 0.2 7.2 6.6 ± 0.3 7.2 
Phenylalanine 0.7 ± 0.1 11.5 0.7 ± 0.1 12.1 3.9 ± 0.3 8.9 4.1 ± 0.3 8.9 
Tryptophan - - - - 
     
Gly/Ala ratio 1.27 1.24 0.68 0.65 
a
LC/SC ratio 0.38 0.30 0.41 0.42 
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Table 5.3B. Amino acid composition of fibroin protein from the silkworm species as determined by the developed MEKC method 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a
LC, long chain amino acids and SC, short chain amino acids. 
n=5 G. postica 
% ± SD              RSD 
E.  bahuniae 
% ± SD                  RSD 
B. mori 
% ± SD                     RSD 
A. panda 
% ± SD               RSD 
Non-polar   
Glycine 36.9 ± 1.2 4.3 28.2 ± 1.1 3.4 44.9 ± 1.6 4.0 28.9 ± 0.9  4.1 
Alanine 28.1 ± 1.0 4.1 40.3 ± 1.9 3.7 29.2 ± 1.1 4.6 54.3 ± 1.7 3.4 
Proline  2.5 ± 0.2 7.6 0.8 ± 0.1 9.4 0.5 ± 0.1 10.8 1.6 ± 0.2 7.3 
 Valine 1.6 ± 0.2 8.1 0.6 ± 0.1 12.1 2.4 ± 0.2 7.8 0.3 ± 0.1 15.5 
Leucine 1.5 ± 0.2 8.3 1.2 ± 0.1 8.9 0.7 ± 0.1 11.7 0.3 ± 0.1 15.0 
Isoleucine 0.8 ± 0.1 11.2 0.3 ± 0.1 16.8 0.4 ± 0.1 15.9 0.2  19.1 
Methionine 0.3 ± 0.1 14.5 -  0.2  18.8  - 
Polar   
Serine 12.1 ± 0.3 4.6 9.6 ± 0.3 5.5 9.6 ± 0.4 5.8 4.2 ± 0.2 5.0 
Threonine 0.9 ± 0.1 11.4 0.6 ± 0.1 12.7 0.3 ± 0.1 15.0 0.2  18.5 
Cysteine 0.1 18.9 detected  0.1  19.1 detected  
Acidic  
Aspartic acid 4.2 ± 0.2 6.8 3.2 ± 0.2 6.6 0.3 ± 0.1 12.1 2.9 ± 0.2 8.2 
Glutamic acid 1.2 ± 0.1 9.0 1.1 ± 0.1 8.4 0.6 ± 0.1 11.3 0.5 ± 0.1 13.3 
Basic  
Arganine 6.5 ± 0.3 5.6 4.9 ± 0.3 6.7 0.2  17.1 2.9 ± 0.2 6.6 
Lysine 1.1 ± 0.1 7.9 0.6 ± 0.1 12.3 0.6 ± 0.1 12.2 0.3 ± 0.1 14.6 
Histidine 0.2  17.1 0.3 ± 0.1 13.3 0.2  18.3 0.4 ± 0.1 13.8 
Aromatic  
Tyrosine 8.3 ± 0.3 6.5 7.8 ±0.4 6.1 9.6 ± 0.3 6.6 2.9 ± 0.2 8.4 
Phenylalanine 0.8 ± 0.1 11 0.6 ±0.1 11.5 0.7 ± 0.1 11.7 0.2  18.7 
Tryptophan - - - - 
     
Gly/Ala ratio 1.31 0.69 1.54 0.53 
a
LC/SC ratio 0.30 0.28 0.19 0.14 
  
72 
 
The ratio of glycine to alanine (Gly/Ala ratio) in fibroin is important in defining the 
crystalline arrangement of silks. Gonometa fibroin had a higher glycine than alanine content 
resulting in a Gly/Ala ratio greater than 1, similar to B. mori fibroin.  However, because the 
glycine content in B. mori fibroin (44.9 %) was higher than in the Gonometa fibroin (~36 %), 
the Gly/Ala ratio differed significantly suggesting a distinction in the primary structure and 
organization of residues in the two species. Our result for the Gly/Ala ratio for G. 
rufobrunnea (1.27) is different to that reported by Freddi et al. (1.51) [34]. This was because 
the alanine content reported in the two studies differed greatly though the reason for the 
discrepancy was unclear. However, statistical analysis showed there was no significant 
difference between the two studies for the results of the remaining amino acids. In contrast to 
Gonometa and B. mori fibroin, A. mimosae and E. bahuniae fibroin had more alanine than 
glycine, resulting in a Gly/Ala ratio less than 1. This is similar to reports from several Asian 
silks belonging to their Saturniidae family [292]. A. panda (Thaumetopoeidae family) also 
showed a higher alanine content but due to the greater amount of glycine present, it exhibited 
a different Gly/Ala ratio to A. mimosae and E. bahuniae fibroin.  
 
The LC/SC (long chain/ short chain) ratio provides insight on the relative degrees of 
crystallinity in fibroin by comparing amino acids making up the crystalline region (glycine, 
alanine and serine) and amorphous region (the rest of the amino acids) [293]. Long chain 
amino acids are often bulky and considered β-sheet breakers as they disturb the close packing 
of adjacent fibroin molecules. A high content of these amino acids (higher LC/SC ratio) 
therefore implies less structural regularity and a greater occurrence of less ordered regions. 
Higher LC/SC ratio calculated for Gonometa and Saturniidae fibroin suggests a lower order 
and more amorphous content compared to the B. mori silk with a lower LC/SC ratio (Table 
5.3). Most of the bulky and polar amino acids such as arginine and aspartic acid were more 
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abundant in Gonometa fibroin than the other silks. Amongst the Saturniidae fibroin, E. 
bahuniae had larger amounts of leucine and phenylalanine than A. mimosae fibroin resulting 
in E. bahuniae having a significantly higher LC/SC ratio.  A. mimosae composition in this 
respect is similar to that reported for D. japonica [292] whilst that of E. bahuniae is more 
comparable to the Antheraea silks [292]. A. panda fibroin exhibited the lowest ratio 
indicating a greater degree of structural order than the other silks in this study.  
Serine and tyrosine, which are mostly part of the crystalline region, also attained fairly high 
concentrations in the fibroins. With the exception of A. panda fibroin, serine and tyrosine 
content ranged from about 7 to 13.5 % and 6.5-11 % respectively. A. panda fibroin had much 
smaller quantities of serine (~4.2 %) and tyrosine (~2.9 %).  Serine plays an important role in 
stabilization of the  protein structure by providing hydrogen bonds to neighbouring backbone 
N–H and C=O groups [294]. Tyrosine is also considered as a β-sheet favouring amino acid as 
it participates in hydrogen bonding and in aromatic- aromatic interactions within the silk 
[295].  
The quantity of the polar and non-polar amino acids in the amorphous region gives an 
indication of the potential reactivity of the fibroin. Polar amino acids possess amino, 
carboxyl, and hydroxyl groups that are available for functional modifications whilst the non-
polar amino acids do not provide these binding sites. When found within the protein 
structure, the polar groups form hydrogen bonds amongst themselves and are therefore not 
readily available for additional chemical interactions. Most of these polar groups are however 
found on the outer surfaces of proteins and are therefore available to take part in several 
chemical reactions [296, 297]. The presence of these amino acids in the fibroin therefore has 
an influential role in determining the chemical and physical properties of the protein. The 
Gonometa and Saturniidae fibroins showed a significantly higher content of polar amino 
acids compared to B mori. It can be inferred that these African silks have greater potential for 
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opportunities in blending or reacting with other materials. Though A. panda fibroin had much 
smaller quantities of polar amino acids than the other African fibroins, they were more than 
those found in B. mori SF.  
The polar amino acids were mostly evenly distributed between the acidic and basic amino 
acids. Basic amino acids have been of more interest to biomedical researchers as it has been 
shown that they play a key role in cell attachment and growth when fibroin was used as a 
substrate for cell and tissue growth [145]. Arganine is also part of the tripeptide sequence 
(arginine-glycine-aspartic acid) that has also been identified as promoting cell attachment 
[145]. Results of this work thus suggest that fibroin from the African silkworm species, in 
particular, Gonometa fibroin, has prospective use in cell and/or tissue culture, possibly 
performing better than B. mori fibroin.  
Not much variation was noted between the amino acid compositions of the same species 
sampled from different areas (Table 5.3A). It was thus assumed that the small differences 
would not have a great impact on their physical properties and therefore results reported 
represent the particular species. 
5.5  Cocoon and fibre properties 
Cocoon constructs, including some in this study [298, 299] have shown great diversity 
depending mostly on the species, environment and function of the cocoon. As seen in Figure 
4.2 (experimental section), cocoons from the different silkworm species showed differences 
in size, colour and architecture. Gonometa cocoons had a similar oval shape and were light 
grey to light brown in colour. Saturniidae cocoons showed more variance with A. mimosae 
cocoons having unique perforations and a shiny silver colour whereas E. bahuniae cocoons 
had a light brown colour. Similar to reports in literature [48], A. panda silkworms had unique 
constructs with a large brown cocoon which enclosed as many as 60 smaller light yellow 
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cocoons. The cocoons from the wild species were much tougher than those of B. mori. As a 
consequence, harsher degumming conditions were required than those for B. mori cocoons. 
Wild silkworm cocoons tend to be more resilient in order to withstand the harsh 
environmental conditions they are exposed to in their natural habitats such as extreme heat or 
cold [58]. SEM images of the cocoons showed that the silk fibres from G. rufobrunnae, G. 
postica, A. panda, A. mimosae and E. bahuniae were heavily cemented with sericin making a 
compact structure (Figure 5.6). B. mori cocoons had less sericin coating than the other 
cocoons with individual fibres visible. It has been reported that the amount of sericin 
produced and its extent of binding the fibres is greatly determined by the biology and habitat 
of the insects [299]. A white deposit observed on the surface of Gonometa and A. mimosae 
cocoons has been previously ascribed to calcium oxalate from silkworm excretions [293, 
298]. A recent comprehensive study on cocoons from various silkworm species suggests that 
the calcium oxalate may have a structural function in the cocoon construct, though further 
investigations are needed in this respect [299].  
Complete sericin removal is very important for quantitative analysis of the amino acids in the 
fibroin as well as determination of some physical properties of the fibroin. SEM examination 
of the degummed cocoons showed individual silk fibres with a clean surface free from sericin 
indicating proper degumming (Figure 5.7). Further examination of the fibres showed they had 
considerable variability in shape and size.  Diameters ranging from 18-33 µm were observed 
for G. postica and 13-24 µm for G. rufobrunnae, similar to those for E. bahuniae (16-25 µm). 
Fibres from A. mimosae cocoons were the largest in diameter ranging from 33-46 µm. A. 
panda fibres were very fine and had diameters around 9-13 µm, similar to B. mori fibres (7 
to12 µm). Though silk fibre diameter has not been a point of discussion in technological 
applications, it is an important characteristic in the textile industry influencing properties 
such as abrasion resistance, softness and stiffness [300]. 
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Figure 5.6. SEM images of a) B. mori, b) G. rufobrunnae (Bots) c) G. rufobrunnae (Zim) d) G. postica, e) A. mimosae, f) A. panda (outer), g) A. panda 
(inner) and h) E. bahuniae undegummed silk fibres
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Figure 5.7. SEM images:  a) B. mori, b) G. rufobrunnae (Zim) c) G. rufobrunnae (Bots) d) G. postica, e) A. mimosae, f) A. panda (outer), g) A. panda 
(inner) and h) E. bahuniae degummed silk fibres 
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Various cross sectional shapes, mostly round, oblong, triangular and elliptical were observed 
in the fibroins as exemplified by G. postica fibres (Figure 5.8). 
 
5.6  FTIR and Raman Spectroscopy 
Infrared (IR) spectroscopy studies can provide useful data regarding the secondary structure 
of proteins. The technique takes advantage of groups of atoms that exhibit characteristic 
vibrational bands irrespective of their parent molecule [301]. This makes it possible to 
analyze various protein conformations depending on the position and intensity of the 
observed peaks. SF exists mainly in the three previously described conformations; namely 
random coil, α-helix and β-sheet. Using FTIR, the characteristic absorption bands for random 
coil are around 1647 cm
−1 
(amide I), 1541 cm
−1
 and 660 cm
−1
 (amide V), α-helix absorption 
peaks around 1655 cm
−1
 (amide I), 1546 cm
−1
 (amide II), 1270 cm
−1
 (amide III), 625 cm
−1
 
Figure  5.8. Cross sectional images of G. postica a) bundle fibres and b) fibres embedded in resin. 
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(amide V), and β-sheet absorption around 1630 cm−1 (amide I), 1520 cm−1 (amide II), 1240 
cm
−1
 (amide III), 965 cm
−1
  (amide IV) and 695 cm
−1
 (amide V) [128].  
The FTIR spectra of fibroin from all the silk species in the study showed the strongest peaks 
around 1514 and 1622 cm
-1
, which are attributed to the β-sheet structure (Figure 5.9).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.9. FTIR spectra of silk fibroin from different silkworm species 
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Less prominent peaks seen at 698 and 1240 cm
-1
 are also indicative of β-sheet structure. 
Recently, it was deduced that a peak around 1050 cm
-1
 is characteristic of glycine-alanine 
(poly-Gly-Ala) sequences in the fibroin structure [302]. A peak was noted around this region, 
with varied intensity, for all the silk fibroins. These linkages have never been reported for the 
Saturniidae species and therefore cannot be attributed to the poly-Gly-Ala polypeptides until 
further conclusive research has been done. A shoulder peak at 1270 cm
-1
 (α-helical structure) 
was seen in the spectra for B. mori and A. panda fibroin but was not clear in the spectra for 
the other silks. Another shoulder peak was present around 1696 cm
-1
 in the fibroin spectra 
with the exception of those of the Gonometa fibroins. The peak is attributed to β-turn 
conformation of the hairpin-folded antiparallel β-sheet structure [303, 304]. Further analysis 
of the spectra showed a peak around 967 cm
-1
 for the Gonometa, A mimosae, A. panda and E. 
bahuniae fibres attributed to β-sheet crystallinity relating to alanine-alanine (poly-Ala) 
linkages [293]. A small peak noted around 972 cm
-1 
in the B. mori fibroin spectra could not 
be attributed to the poly-Ala linkages as they have not been previously reported for this 
species. Similar to results on the amino acid analysis, the spectra for the A. panda inner and 
outer silks were almost identical. G. postica also showed similar spectra to that of G. 
rufobrunnae. The Saturniidae silks (A. mimosae and E. bahuniae) exhibited very similar 
molecular conformation to reports for other Asian silks from the same family [305, 306]. 
Overall, the results show that the silk fibroin from the species examined in this study is 
mainly of β-sheet structure with some α-helix structure also existing. The Saturniidae and 
Gonometa silks showed similarities and were different from B. mori fibroin. Interestingly, A. 
panda showed a very similar structure to B. mori fibroin. 
Raman spectroscopy was also utilized as an additional technique in analyzing the silk 
structure. As seen in Figure 5.10, the Raman spectra of all the silk fibroins showed strong 
peaks around 1666 cm
-1
 and 1090 cm
-1
 which is evidence of β-sheet crystallinity [307, 308]. 
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A peak at 904 cm
-1
 associated with poly-Ala sequences [308] was observed in the fibroin 
spectra with the exception of B. mori fibroin thus confirming the absence of poly-alanine 
linkages in B. mori SF. Other peaks seen have been attributed in literature to various 
structures. A peak seen around 1225-1230 cm
-1
 in the fibroins has been ascribed to β-sheet 
structures [205, 309].  
 
Figure 5.10. FT-Raman spectra of silk fibroin from different silkworm species 
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Minor peaks around this region were observed for the other silk species. Additional bands at 
about 1615 cm
-1 
 as well as 854 cm
-1
 have been assigned to the side chains of  the amino acids 
phenylalanine and tyrosine respectively [308, 310]. The data provided by FTIR and Raman 
spectroscopy highlights how the proportions of the amino acids determine the primary 
structure and hence the secondary structure of the different fibroins. In the Gonometa fibroin, 
the glycine content is lower than in B. mori fibroin though their alanine content is very 
similar. This may possibly promote alanine-alanine linkages in the Gonometa fibroin in 
addition to glycine-alanine linkages. A. panda, A. mimosae, and E. bahuniae have higher 
alanine than glycine content which promotes primary sequences with alanine-alanine 
linkages. It can be assumed that the lower amount of glycine in the Saturniidae and A. panda 
fibroin (less than 30 % in all), is insufficient to promote significant poly-Gly-Ala linkages, 
unlike that for Gonometa and B. mori fibroin (more than 35 %).  
 5.7  XRD analysis 
XRD is useful in examining the structure of crystalline and semi-crystalline polymers and 
was used to study the silk fibroin in this work. X-ray diffraction studies were conducted to 
elucidate the physical structure by identifying the positions of the diffraction peaks. Peaks 
were observed for all the fibroins examined (Figure 5.11). The peaks for E. bahuniae and A. 
panda were not as intense as the other fibroins, but are clearly visible in the insert on Figure 
5.12. All the fibroins exhibited peaks around 20.5º and 24.5º corresponding to crystalline 
spacings of 4.35 Å and 3.62 Å respectively. These peaks are evidence of the β-sheet 
crystalline structure of the fibroin [90, 128]. There have also been reports suggesting that the 
above mentioned peaks are indicative of a concurrence of an amorphous matrix with a β–
sheet crystalline structure [311]. The African fibroins exhibited additional peaks around 17º, 
16.5º and 15.5º for Gonometa, Saturniidae and A. panda respectively. These peaks were 
absent in the B. mori fibroin.  
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Earlier research by Warwicker attributed different peaks seen in diffractograms to varying 
dimensions of the unit cell of the crystallites in the different fibroins [312]. The size of the 
crystallites are dependent on the amino acids making up the crystalline components, which 
further highlights the impact of amino acid composition on the structure of the fibroins. The 
XRD data therefore provides further evidence of a distinct difference in the crystalline 
structure of the wild African fibroins and B. mori fibroin. 
Results for A. mimosae and E. bahuniae are in agreement with those reported for other 
species belonging to the Saturniidae family, which are mainly composed of alanine-alanine 
sequences [293]. The data of the African fibroins, though similar, also suggest there are 
Figure  5.11. XRD analysis of silk fibroin from different silkworm species 
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differences amongst them. Study using advanced X-ray techniques (for instance synchrotron 
based) can be used to further elucidate differences in crystalline structure of the fibroins. 
Quantitative determination of the different phases (crystalline and amorphous) could also 
prove useful in examining differences noted for the fibroins. This however could not be done 
in this study due to an absence of suitable standards for the different phases.   
5.8 Thermal Analysis 
 Thermal properties of the silks were examined using TGA and DSC techniques. 
Thermogravimetric (TG) curves of the silk fibroins are shown in Fig 5.12. An initial weight 
loss occurred below 100 °C which is widely attributed to loss of water. The fibres showed 
thermal stability up to about 200 °C after which they showed initial stages of decomposition. 
The thermograms were then characterized by rapid mass loss with over half of the fibroin 
mass degraded at 400 °C. Differential weight loss (DTG) curves provided a clearer depiction 
of the degradation steps as they directly relate to specific thermal decomposition stages 
(Figure 5.13). Unlike B. mori fibroin, fibroins from the African silkworm species were 
characterized by several degradation steps. A small degradation peak at 230 °C seen for 
Gonometa and Saturniidae fibres is associated to the loss of low molecular weight gases 
(H2O, CO2, NH3), resulting from the breakdown of side chain groups of amino acid residues 
as well as from cleavage of peptide bonds in the amorphous region of the silk [313, 314]. The 
main peaks of degradation between 350 °C and 375 °C are associated with mass loss due to 
the permanent decomposition of the fibroin molecules. The Gonometa and Saturniidae fibres 
showed very similar degradation patterns with maximum decomposition occurring around 
375 ° C for the fibres. A. pernyi and other silks belonging to the Saturniidae family have also 
been found to undergo a number of decomposition steps attributed to their crystalline 
structure and amino acid composition [314].  A. panda exhibited its maximum degradation 
around 360 °C, the lowest amongst the African fibres. The main degradation peak was 
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around 350 °C for the B. mori, which therefore implies the African wild silk fibres are 
relatively thermally more stable. No assignment has been previously given to the peaks seen 
above 400 °C but they may possibly represent further decomposition of the silk fibroin 
structure. However, TGA combined with FTIR can give more insight into the specific 
structural degradation of the fibroin at the different stages of heating. 
  
 
DSC curves of the fibroins (Fig 5.14) showed an endotherm below 100 °C which is due to 
absorption of heat for removing water.  In addition to this dehydration endotherm, B. mori 
fibroin showed one other main peak around 320 °C. Similarly, A. panda also showed one 
major peak around 365 °C. The peaks found between 320 and 365 °C represent the 
degradation of the β -sheet structures of the protein. This data, similar to TGA results, shows 
Figure  5.12. TGA curves for the silk fibroins 
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B. mori fibroin is less thermally stable than the African fibroins. This may be due to the 
higher thermal stability of poly-Ala β-sheets [315] which are present in the African fibroins. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
With the exception of B. mori and A. panda, the rest of the fibroins exhibited another 
significant peak around 228 °C which is attributed to the strong molecular motion and 
rearrangement within the α-helix crystals in the amorphous region [293]. DSC and TGA 
results however vary with regards to A. panda fibroin. TGA shows it to be slightly less stable 
than the other African fibroins whilst DSC results show the main decomposition endotherm 
at a higher temperature than the other fibroins.   
Figure 5.13. DTG curves for the silk fibroins 
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Figure 5.14. DSC curves for the silk fibroins 
 
5.9  Mechanical properties  
The quality of the silk fibres can be assessed by examining mechanical properties such as 
tensile strength, tenacity, Young’s modulus and toughness. Table 5.4 shows the results of the 
measurements of tenacity and tensile extension done for fibres from the different species. The 
diameters for all the silks were determined using optical imaging as exemplified in Figure 
5.15. Tenacity measures the strength of a fibre or yarn by determining the point at which it 
breaks; the higher the fibre tenacity, the higher the strength of the fibre. B. mori silk showed 
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the highest tenacity of all the fibres tested. Amongst the African silks, A. panda had the 
highest tenacity followed by G. rufobrunnae, G. postica, A. mimosae and E. bahuniae.  
  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.15. Optical image for cross section of A. panda silk fibres 
 
The mechanical performance of fibroin is governed to a large extent by its chemical structure, 
particularly the amino acid composition and sequence. 
The larger amount of bulky amino acids in their structure hinder close packing of fibroin 
chains which enables formation of strong hydrogen bonds between the chains. A. panda 
consists mostly of glycine (28.9 %) alanine (54.3 %) and serine (4.2 %) and a small 
percentage of amino acids with bulky side groups. This suggests an extensive crystalline 
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region and less amorphous content than the other African silks hence it exhibited the highest 
tenacity amongst the African silk fibres. 
The strength at break of E. bahuniae and A. mimosae fibroin was about half that of B. mori. 
Literature however suggests that poly-alanine β-sheets (predominant in E. bahuniae and A. 
mimosae fibroin) exhibit a higher tensile strength than the poly-Gly-Ala β-sheets 
(predominant in B. mori fibroin) due to a higher binding energy [316]. The authors indicated 
that in poly-Ala rich segments, hydrophobic interactions interlock adjacent chains into stable 
antiparallel β-sheets, whereas in the poly Gly-Ala rich segments, the glycine residues are not 
capable of forming the same types of hydrophobic interactions hypothesized for an alanine 
residue [316]. This ultimately results in less stable β-sheets in poly Gly-Ala regions due to 
fewer chain interactions.  
 
Table 5.4. Mechanical properties of the silk fibroins 
Properties E. bahuniae  G. 
rufobrunnae  
B. mori A. mimosae A. panda G. postica 
 
Mean 
Tenacity @ 
Max.Load 
(cN/tex) 
 
CV% 
 
12.08 
 
 
 
 
18.7 
 
15.89 
 
 
 
 
30.3 
 
32.11 
 
 
 
 
23.9 
 
12.11 
 
 
 
 
16.39 
 
24.69  
 
 
 
 
16.43 
 
15.1  
 
 
 
 
20.3 
Mean Tensile 
extension@ 
max. 
Load (mm) 
 
CV% 
0.73  
 
 
 
 
18.4 
1.04 
 
 
 
 
34.3 
0.62  
 
 
 
 
 29.5 
0.79 
 
 
 
 
29.62 
0.72  
 
 
 
 
40.8 
1.08  
 
 
 
 
7.17 
Mean fibre 
diameter (μm) 
 
 
CV% 
14.8 
 
 
 
30.9 
14.7  
 
 
 
31.7 
12.1 
 
 
  
26.9 
27.0  
 
 
 
43.7  
11.9 
 
 
 
31.9 
16.2  
 
 
 
34.4 
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It has also been noted that mechanical properties such as tenacity are also related to the finess 
of the silk fibres. A general rule established from work done by Meredith [317] is that the 
finer the silk, the higher the tenacity and the lower the breaking extension. This is somewhat 
reflected in the results obtained in this work, more so for the tensile extension. 
G. postica and G. rufobrunnae silks had the highest extension values of all the silks. When 
silks are stretched, deformation begins in the amorphous regions, therefore the proportion of 
the amorphous region and the interaction of the chains in this region will strongly determine 
the resistance to extension. Under tensile load, the semi-amorphous regions unravel first 
owing to breaking of hydrogen bonds, which accounts for the high level of extensibility 
observed in silk [318]. The presence of more bulky amino acids in the amorphous region also 
allows the SF chains to flow easier, conferring elasticity and better extension of the fibre 
[319]. Gonometa fibroin is comprised of a more extensive amorphous region than the other 
silks which may explain their higher extension. E. bahuniae and A. mimosae fibroins had 
comparable extension to A. panda fibroin and slightly higher extension than B. mori fibroin.  
Data obtained in this work is in reasonable agreement with some other published data for 
degummed fibres. Kushal and Murugesh determined that because the non-mulberry silks 
contain more amino acid residues with bulky side groups they exhibit higher extensibility 
[319]. Teshome et al. revealed that the African wild silk fibres belonging to the Saturniidae 
silks showed larger extensibility when compared with the Thaumetopoeidae [36].  They also 
reported that the African wild silk fibres had a lesser breaking elongation than B. mori, which 
is contrary to our results.  
One of the factors that may significantly contribute to variances in mechanical properties is 
the degumming process. Some of the fibres from the wild silks show some damage (Figure 
5.16), possibly due to the intensive degumming procedure as reported by other researchers 
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[320]. It was also noted that the cocoons consisted of several different layers and some of the 
fibres could be more easily pulled out in some layers compared to others. 
 
 
This suggests the extent of cementing the fibroin with sericin differs which may result in 
some of the fibres being exposed to the degumming solution for too long leading to the 
damage observed. This damage has proven to be detrimental to the mechanical properties of 
Figure 5.16. SEM images of damage done to silk fibres from a) A. panda (inner), b) G. postica c) G. 
rufobrunnae and d) A. panda (outer) during degumming 
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the silk [321, 322] and affects its performance as a textile material. However, for use as 
biomaterials, the fibroin is processed by first dissolving degummed silk; thus the inherent 
mechanical properties of the silk fibres are lost and any damage caused by the removal of 
sericin is not detrimental. 
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CHAPTER SIX 
FABRICATION AND CHARACTERIZATION OF ELECTROSPUN 
SILK NANOFIBRES 
6.1 Introduction 
This chapter covers the processing of silk fibroin into regenerated silk (RSF) as well as 
fabrication and characterization of Gonometa silk fibroin nanofibres. Part of this work has 
been published in the Journal of Macromolecular Research [323].  
6.2 Dissolution of degummed silk fibroin  
Dissolution of fibroin is a necessary step in preparing RSF from silk fibres prior to processing 
into morphologies for biotechnological applications such as sponges, films and nanofibres. 
Commonly used concentrated salt solutions achieve dissolution by binding with polar 
residues in the fibroin causing disruption of van der Waals forces and hydrogen bonds in 
fibroin molecules [324]. Although several solvent systems have been found effective for 
dissolution of fibroin from other species, there has been no information on the dissolution of 
the African fibroins prior to our work [323]. Recently, Teshome and co-workers also made a 
contribution in this regard [325]. This section thus gives a detailed account of our findings on 
the ability of several solvent systems to dissolve the fibroin from some African silkworm 
species. The studies also provide further insight on the chemical nature of the fibroins as their 
dissolution involves interaction of solvent ions with functional groups present within the 
fibroin structure.  
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6.2.1 Effect of different aqueous salts and concentration  
Results obtained on the solubility of the fibroins in various aqueous salts at different 
concentrations are presented in Table 6.1. G. postica and G. rufobrunnae fibroin dissolved 
easily in 9.5 M Ca(NO3)2 producing solutions of approximately 22 % (w/v) after 5 h 
dissolution. A. mimosae, A. panda and E. bahuniea fibroin showed the lowest solubility in 
Ca(NO3)2 with less than 3% of the fibroin dissolving.   
Table 6.1. Dissolution of silk fibroins in aqueous salt solutions 
*: +++ = Very soluble, ++ = Soluble, += Slightly soluble, × = Insoluble 
 
Gonometa fibroin also dissolved easily in 9.5 M LiBr whilst A. mimosae, A. panda and E. 
bahuniae fibroin were again practically insoluble with less than 2 % dissolving. None of the 
African fibroins were solubilized using CaCl2 and LiCl solutions. In stark contrast to the 
African fibroins, B. mori fibroin dissolved in all salt solutions investigated, though solubility 
in CaCl2 and LiCl solutions was relatively low (< 5 % w/v). For the salts that solubilized the 
African fibroins, the dissolution process was slower than that observed for B. mori fibroin. 
The effect of different concentrations of the salts was also examined. As expected, lower 
 Ca(NO3) 2 CaCl2 LiBr LiCl 
 5 M  7 M  9.5M  Up to 
saturated 
solution 
5 M  7 M  9.5 M Up to 9.5M 
G. postica × ++  +++
* 
× × ++ +++ × 
G. rufobrunnae  × ++ +++ × × ++ +++ × 
A. mimosae × × + × × × + × 
A. panda × × + × × × + × 
E. bahuniaea × × + × × × + × 
B. mori + ++ +++ + + ++ +++ + 
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concentration of the salt solutions resulted in lower solubility of the fibroin from all the 
species.  Only B. mori and Gonometa fibroin dissolved in 7 M salt solutions.  
There was no dissolution of any of the fibroins when 5 M solutions of the salts were used 
(Table 6.1). The results suggest that there are several factors affecting solubility of the 
fibroin. Firstly, there is evidence the solubility of fibroin is highly dependent on the type of 
salt ions available for the process. The ionic strength of salts has been highlighted as a key 
parameter in protein solubility. Ions with high charge density, such as Ca
2+ 
and Mg
2+
, are 
strongly hydrated and tend to increase protein solubility by interacting more with amide 
moieties in proteins than less hydrated cations (Li
+
, K
+
). Studies have further established that 
the dissolution process is more dependent on the anions, possibly because of their larger size 
compared to cations [326, 327]. Nucleophilic attack by the anions on the abundant 
electrophilic centres (hydroxy, amide, amino groups) in the fibroin results in the disruption of 
the hydrogen bonded chain networks. Br
-
 and NO3
-
 are more nucleophilic than Cl
-
 and would 
thus have better protein solubilizing power. This possibly explains why the fibroins dissolved 
more in LiBr and Ca(NO3)2 but not in LiCl and CaCl2 solutions.  
Secondly, the variation observed in solubility can be attributed to differences in their 
structure as influenced by their amino acid compositions. The amorphous region of fibroin is 
the one that is open to interactions with other compounds and/or solvents that can cause 
changes in structure, and studies have shown that silk dissolution starts in this region [328]. 
The larger proportion of polar groups in the Gonometa and Saturniidae silks could result in 
increased networking of fibroin molecules through hydrogen bonding, possibly creating a 
stronger amorphous structure than the other fibroins. It would thus be expected that the 
Gonometa fibroin would show the least solubility with multiple bonds requiring disruption. 
Results however do not reflect this as Gonometa fibroin was the most soluble of the African 
fibroins. On the other hand, a larger amount of polar groups would provide multiple sites for 
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interaction with salt molecules causing dissolution to proceed faster than in fibroin with less 
polar groups.  
This assumption, again, fails to address the stark differences between the Gonometa and 
Saturniidae fibroin as well as the easier dissolution of B. mori fibroin. A more plausible 
explanation can be found in the crystalline structures of the different silks. In terms of the β-
sheet forming residues, B. mori fibroin has (Gly-Ala)n units, Gonometa SF has (Gly-Ala)n 
and (Ala-Ala)n units and A. mimosae, A. panda and E. bahuniae are composed of (Ala-Ala)n 
repeats. Packing of (Ala-Ala)n beta sheets is more compact than (Gly-Ala)n [316] which may 
hinder penetration of water and solvent ions for dissolution of the fibroin. Thus, the order of 
dissolution observed was B. mori fibroin being the most soluble and A. mimosae, A. panda 
and E. bahuniea being the least soluble. This suggests that the crystalline composition is the 
major determining factor in its solubility and further investigations are required to fully 
understand the process as this would greatly assist in dissolution of the more resistant 
fibroins. Results of percentage dissolution are not directly comparable with the report by 
Teshome et al. because of difference in the conditions of the studies. Both studies are 
however in agreement that LiBr was a very good solvent for B. mori and G. postica fibroin 
and less effective for A. mimosae, A. panda and E. bahuniea fibroin. Also, CaCl2 proved to 
be a poor solvent for dissolution of the African silk fibroins.  
6.2.2 Effect of organic ternary mixtures  
Some researchers have reported enhanced dissolution of fibroin by adding organic solvents 
such as methanol and ethanol to salt solvents [329]. The organic component and the salt ions 
act cooperatively to dissolve the fibroin. As the salt ions break down hydrogen bonds 
between the β-sheets, the organic component (methanol/ethanol) penetrates the hydrophobic 
regions of fibroin and makes the molecules hydrophilic thereby enhancing dissolution [330].  
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Table 6.2. Dissolution of fibroins in ternary solvent systems 
*: +++ = Very soluble, ++ = Soluble, += Slightly soluble, × = Insoluble 
 
Under the same experimental conditions used for the aqueous salt solutions, there was a 
decrease in solubility for both Gonometa fibroins from 22 % (w/v) in aqueous salts to ≈ 10 % 
(w/v) in the salt-organic solvent mixtures (Table 6.2). No improvement in dissolution was 
observed for the fibroins when methanol and ethanol were added to CaCl2 and LiCl salt 
solutions. Although the lower solubility was not fully understood, it could possibly be 
explained by the fact that water miscible organic solvents have been found to lower the 
dielectric constant of salt solutions. When the dielectric constant is reduced, charge-dipole 
and dipole-dipole interactions are thus promoted resulting in reduced protein solubility [331]. 
The interaction of ternary organic solvents with fibroin has been described by some 
researchers. In a study by Perez-Rigueiro et al. [332], the authors explained the important 
role water plays in swelling the amorphous region and disrupting inter- and intra-molecular 
hydrogen links in the protein. Incorporation of organic solvents such as methanol and 
ethanol, which are desiccants, to the aqueous salts can increase protein-protein hydrogen 
bonding reducing the solubilizing power of the solvent mixture [332].  
 Ca(NO3) 2. 4H2O 
/MeOH (3:1)  
CaCl2/EtOH/H2O 
(1:2:8) 
LiBr/H2O/EtOH LiCl/ H2O/EtOH   
G. postica ++ × ++ × 
G. rufobrunnae  ++ × ++ × 
A. mimosae +  × + × 
A. panda + × + × 
E. bahuniae + × + × 
B. mori +++ +++ +++ + 
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The behaviour of B. mori fibroin in the ternary solvents was unlike that of the African silks. 
B. mori fibroin dissolution was enhanced with the addition of the organic solvents with the 
fibroin dissolving almost immediately when added into the solvent. From these results, we 
concluded that it is possible that the increased quantity of polar groups (mostly in the 
amorphous region that dissolves first) Gonometa fibroin, may explain the difference in 
solubility compared to B. mori. Because of the large amount of polar amino acids, the 
enhancement of hydrogen bonding network would reduce the dissolution of the fibroin as we 
observed in our work. Overall, these results highlight the complexity of the dissolution of 
fibroin, the process influenced by the structure of the silk and interactions between the 
protein molecules, water and the salt ions. The extent of the amorphous region appears not to 
influence dissolution as much as the composition of the crystalline regions when using 
aqueous salt solutions as we see that B. mori and A. panda fibroin showed dissimilarity in 
solubility despite both having a smaller and comparable amorphous region. We can therefore 
assume that the type of linkages in the crystalline region may have an impact on the solubility 
shown by the trend in dissolution of the fibroins.   
6.3 Electrospinning of RSF 
Due to poor dissolution of A. mimosae, A. panda and E. bahuniea in the solvents utilized in 
this study, it was impractical to carry out electrospinning experiments due to the little 
amounts of regenerated fibroin obtained. We therefore report results on the electrospinning of 
only Gonometa SF as it dissolved quantitatively in the solvents available in this study. 
The process of electrospinning requires optimization of several parameters for defect free 
nanofibres to be produced. Several authors have highlighted, through systematic 
investigations, the significance of various electrospinning parameters in fabricating 
nanofibres [333-335]. Solution concentration, voltage, flow rate and spinning distance were 
  
99 
 
investigated in electrospinning Gonometa SF. Both freeze dried (FD-RSF) and rotavapor 
dried (RD-RSF) solutions were used in the study. 
6.3.1 Selection of electrospinning solvent 
Polymers can be soluble in many solvents but each solvent influences electrospinnability 
depending on its properties. The choice of electrospinning solvent is therefore critical for 
optimal production of nanofibres. A good solvent allows SF chain extension to form 
significant chain entanglements that result in a lower concentration for electrospinning [336]. 
Water, formic acid and trifluoroacetic acid are some of the solvents that have been useful in 
electrospinning SF [208, 212] and were used in assessing electrospinnability of Gonometa 
SF. Despite the numerous reports of successful electrospinning of SF in water, bead free 
fibres could not be formed from the Gonometa aqueous RSF solutions (Figure 6.1a). 
Increasing the concentration of RSF resulted in a thick gel being formed which could not 
flow through the capillary. Highly concentrated solutions of aqueous SF can quickly 
aggregate via hydrogen bonds to form the water insoluble silk II structure [337]. Figure 6.1b 
& 6.1c show fibres electrospun from 25 % (w/v) FD-RSF solutions in FA and TFA. Though 
both solvents produced beaded fibres, TFA solution produced the most promising fibres with 
fewer beads. The differences noted between the two solvents may be due to different solvent 
properties combined with the behaviour of fibroin in solution with each solvent. Jeong et al. 
examined the electrospinnability of fibroin in various solvents and concluded that different 
solvents produce fibres with different morphologies as a result of their solvent properties 
such as surface tension and conductivity [336]. Zhou et al. in their work also reported that 
TFA was a better solvent than FA for electrospinning cellulose acetate due to its higher 
conductivity and lower boiling point as highlighted in Table 6.3 [338]. Considering the 
results obtained, TFA was used as the electrospinning solvent for further experiments. 
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Table 6.3. Solution properties of formic acid and trifluoroacetic acid 
 Conductivity 
(S·m
-1
) 
Boiling point (°C) Surface tension 
(dyn/cm) 
Trifluoroacetic acid 2.6 x 10
5 
72.4 13.63  
Formic acid 6.4 x 10
-5
 100.8 37.67  
 
6.3.2 Effect of concentration on electrospinning of FD-RSF and RD-RSF  
Solution concentration has been reported to be a major determining factor in electrospinning 
of polymers. A critical polymer concentration, which allows sufficient polymer chain 
entanglements, has to be exceeded in order for electrospinning of beadless fibres [339]. 
Below this critical concentration, the polymer solution fragments into droplets before 
reaching the collector when voltage is applied [18]. The electrospinnability of both freeze 
dried (FD-RSF) and rotavapor dried (RD-RSF) was evaluated, as well as quality of resultant 
nanofibres. 
Results showed that there was a difference in the electrospinnable concentration of both FD-
RSF and RD-RSF powders. No fibres were formed when low concentrations of RSF (15 % 
w/v and below) were electrospun. It is probable that SF chain entanglements were insufficient 
to prevent the breakup of the electrically driven jet into droplets. Using FD-RSF, increasing 
solution concentration to 30 % (w/v) resulted in the formation of nanofibres with a mixture of 
beaded and smooth fibres (Figure 6.2b). Although not quantitatively measured, there was a 
visible increase in the viscosity of the RSF solutions with increase in concentration. Smooth 
fibres (without beads) were produced at 40 % (w/v) (Figure 6.2c). The diameters of 
electrospun fibres collected for both Gonometa species at 40 % (w/v) were between 400-1000 
nm. At higher concentrations, the solution was too thick to flow through the needle; therefore 
electrospinning was not possible.  
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Figure 6.3 shows the morphology of fibres that were electrospun from RD-RSF powders at 
27-35 % (w/v) RSF concentrations. The minimum electrospinning concentration at which 
smooth fibres could be formed from RD-RSF powders was 27 % (w/v). Nanofibres with 
diameters ranging from 300 to 760 nm were obtained at this concentration. As the 
concentration was increased, the nanofibre diameters increased with diameters of 540-1200 
nm produced at 30 % w/v and 1-2.5 µm at 35 % w/v. This clearly shows that nanofibre 
diameter is directly related to the polymer solution concentration; the higher the 
concentration of polymer solution, the larger the nanofibre diameters. The differences in the 
spinnable concentrations of FD-RSF and RD-RSF could be attributed to conformational 
changes in the RD-RSF during drying with methanol. Though freezing procedures such as 
freeze drying have been found to induce a certain degree of crystallinity in RSF, addition of 
organic solvents does so to a greater extent [340]. While methanol was primarily used to 
ensure complete removal of water during drying of the RSF, it also probably affected the 
secondary structure of the RSF as it is one of the solvents commonly used in crystallizing 
water soluble silk [305]. There were no definitive differences in the electrospinnability, 
morphology or diameter of the nanofibres from Gonometa postica and Gonometa 
rufobrunnae species. 
6.3.3 Effect of applied voltage 
Figure 6.4 shows SEM images of nanofibres spun at different voltages with other parameter 
fixed. At an applied voltage below 10 kV, only droplets collected on the aluminium foil 
collector possibly because the electrostatic force could not overcome the surface tension of 
the solution. Stable jets and fibres were formed when the applied voltage was greater than 10 
kV. However applied voltages above 15 kV resulted in split jets and the fibres formed also 
showed some defects that included beading.  
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Figure 6.1. SEM images of electrospun fibres using FD-RSF a) 40% in water, b) 25% in FA and c) 25% in TFA 
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Figure 6.2. SEM images of electrospun fibres at a) 20%, b) 30% and c) 40% FD-RSF in TFA 
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Figure 6.3. SEM images of electrospun fibres at a) 27%, b) 30% and c) 35% RD-RSF in TFA 
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6.3.4 Effect of tip to collector distance 
When the nanofibre jet has a short distance to travel to the collector, there is little time for the 
solvent to evaporate, which promotes formation of flat shaped fibres. The distance also 
influences the electric field strength which determines whether electrospinning or 
electrospraying occurs [341]. When tip to collector distance was set at 7 cm, the nanofibres 
appeared wet and were beaded probably due to insufficient time for the complete evaporation 
of the solvent and elongation of the nanofibres (Figure 6.5a). As the distance was increased to 
10 cm, there was no adhesion of the fibres or beading indicating that there was sufficient time 
for solvent to evaporate (Figure 6.5b). At a distance of 13 cm, the nanofibres collected had a 
smaller fibre diameter than those at 10 cm but were frayed and at times not continuous 
(Figure 6.5c). The longer distance afforded more time for elongation of the nanofibres hence 
the finer diameters observed. This was however accompanied by defects on the nanofibres 
indicating that the distance was too long. 
6.3.5 Effect of polymer flow rate 
It is critical that the solution fed to the needle tip balance with that which is drawn from the 
tip for formation of continuous nanofibres [342]. This maintains the Taylor cone at the 
capillary tip and prevents beading of the nanofibres. Flow rates of 0.05-0.08 mL/h allowed 
for a stable cone to be formed at the needle tip and continuous fibres were formed. Higher 
flow rates (above 0.1 mL/h) resulted in nanofibres with slightly larger fibre diameters. Above 
0.3 mL/h, beaded fibres were produced as the RSF solution collected at the needle tip, 
probably due to delivery rate of solution to the capillary tip exceeding the rate at which the 
solution was removed from the tip by electric forces. It was also noted that the flow rate of 
the RSF solution depended on the concentration of the RSF solution.  
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Figure 6.4. Electrospun nanofibres from 40% (w/v) solution of fibroin in TFA, flow 0.05 mL/h, distance 10 cm at (a) 10 kV, (b) 15 kV, and (c) 20 kV 
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 Figure 6.5. Electrospun nanofibres from 40% solution of fibroin in TFA, flow 0.05 mL/h, distance at 15 kV at (a) 7 cm, (b) 10 cm, and (c) 13 cm 
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A lot of adhesion and beading of nanofibres was observed when high flow rates and low 
concentration RSF solutions were used. However, with high concentrations of RSF solutions, 
higher flow rates could be realized without having a significant effect on the morphology and 
diameter of the nanofibres. The optimum conditions for electrospinning Gonometa RSF were 
found to be 0.05 mL/h flow rate, 10 cm tip to collector distance and an applied voltage of 15 
kV. Figure 6.6 shows the pictures of the SF nanofibre mats collected for further analysis. 
 
 
6.4 FTIR spectroscopy 
FTIR analysis was used to examine any structural transformation of SF during the various 
processing stages to produce the nanofibres. Using this technique, some band overlaps have 
been noted for the random coil and α-helix structure in the amide I and amide II region [343, 
344]. Peaks that were observed in these regions were described as either of the structures. 
The main secondary conformation in degummed silk is β-sheet as evidenced by peaks at 970 
cm
−1
, 1522 cm
−1
 and 1628 cm
−1 
(Figure 6.7). The presence of random coil/α-helix structure 
Figure 6.6.  Photographs of Gonometa SF electrospun nanofibres  
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was confirmed by the peak at 1240 cm
−1
. On examination of spectra for FD-RSF and RD-
RSF, similar peaks to those seen for the degummed silk fibre were observed. This suggests 
that the main silk structure was essentially preserved after processing into the RSF powders. 
However, the peak broadness seen around 1650 cm
−1
 for both powders, indicative of random 
coil/α-helix structure, points to the possibility of a change in fibroin structure during 
processing. Despite the differences in their electrospinnable concentrations, there were no 
remarkable differences in conformational peaks observed in the spectra for RD-RSF and FD-
RSF. 
 
Figure 6.7. FTIR spectra for the various silk fibroin formats 
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It was however concluded from XRD analysis that RD-RSF has a more abundant crystalline 
structure than FD-RSF powders (Figure 6.8) as seen by the reduction in the intensity of the 
observed peaks. This suggests increased disorder in the FD-RSF than RD-RSF. The 
crystallinity could however not be quantified due to the absence of a suitable standard for the 
analysis. SF nanofibres showed a major change in conformation when compared to the 
degummed silk and RSF powders (Figure 6.7). 
 
Figure 6.8. X-ray diffractograms for RD-RSF and FD-RSF 
 
Peaks at 970 cm
−1
 and 1628 cm
−1
 relating to β-sheet crystallinity were absent in the spectra 
for the electrospun fibres. The nanofibres exhibited strong peaks at 1648 cm
−1
, 1540 cm
−1 
and 
1240 cm
−1 indicating that their secondary structure was mainly random coil/α-helical. The 
presence of a shoulder peak at 1522 cm
−1 implies that there is some β-sheet crystallinity 
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present in the electrospun fibres. Overall, these results suggest that processes involved in the 
preparation of RSF powders and electrospinning result in secondary structure changes of silk 
fibroin. These changes, however, appear to be more prominent during the electrospinning 
process as seen by the significant degradation of the silk β-sheet structure and increase of 
random coil/α-helical structure in the nanofibres.  
 
6.5 Post treatment of RSF nanofibres 
The nanofibres electrospun from FD-RSF dissolved instantly in aqueous or aqueous-organic 
mixtures, whilst those from RD-RSF maintained their integrity for just over 72 h. Water 
solubility of SF nanofibres is indicative of structural degradation which results in poor 
mechanical strength. This hampers the use of SF nanofibres in applications where mechanical 
and structural integrity is a requirement such as in vascular grafts or as support for cells and 
tissues. There is therefore often a need for post treatment of the nanofibres to restore their 
structural integrity. Immersion and vapour treatments using polar organic solvents are the 
most frequently used techniques to induce β-sheet crystallinity in SF matrices [305, 213]. 
These solvents act by penetrating the amorphous region generating a hydrophobic 
environment which causes aggregation of the hydrophobic chains. Rearrangement within the 
hydrogen bonding network then results in the formation of the water stable silk II structure 
[345, 346].   
Methanol, ethanol, propanol, acetone and chloroform were investigated as solvents to induce 
this transition. In this study, nanofibre mats were immersed for 15 minutes in each solvent to 
ensure maximum crystallization though some reports have revealed that as little as three 
minutes is sufficient to make silk matrices insoluble in water [238]. Water vapour treatment, 
which has been described as an effective yet a mild alternative to induce water insolubility in 
SF [213], was also used. FTIR spectroscopy was used to confirm secondary structure 
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transition in the nanofibres after post-treatment with the various solvents. Generally, the 
solvent treatment resulted in an increase in β-sheet content with a simultaneous reduction of 
silk I structures evidenced by shifting of conformational peaks in the various amide band 
regions (Figure 6.9). The peak in the amide I region shifted from 1648 cm
-1 
for untreated 
nanofibres to 1628 cm
-1
 in the spectra for the nanofibres treated with methanol, isopropanol, 
ethanol and water vapour.  
 
 
Figure  6.9. FTIR spectra of untreated and solvent treated SF nanofibres 
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In the amide III region, the peak at 1540 cm
−1 
disappeared and only the one at 1522 cm
−1 
was 
observed, also showing the successful transition from random coil and/or α-helix to β-sheet 
conformation. Reappearance of the peak at 970 cm
−1
, which is also seen in the spectra for the 
degummed silk fibre, also indicates the increase in β-sheet content.  
 The spectra for chloroform and acetone treated nanofibres were slightly different from those 
observed for the nanofibres treated with the other solvents. They showed broad peak between 
1636 cm
-1
 and 1655 cm
-1
 indicative of a significant presence of random coil conformation /α-
helix conformation. Structural transition to β-sheet structure was evident in that the peak at 
1540 cm
−1 
was less intense whilst the peak at 1522 cm
-1
 is more intense when compared to 
spectra for the untreated nanofibres. The peak at 970 cm
−1
 was also seen in the spectra for 
chloroform and acetone treated nanofibres, though it was weaker than that seen in the spectra 
for nanofibres treated with the alcohols and water vapour. This implies that the transition 
using chloroform and acetone is small with some molecular regions remaining in α-helix and 
random coil conformation. 
 
 It is thus clear that under the conditions used in this work, acetone and chloroform can 
facilitate secondary structure transition to β-sheet crystallinity to a different extent than the 
alcohols and water vapour. This highlights that crystallinity of SF nanofibres can be tailored 
to suit various applications by utilizing different annealing solvents. It is important to note 
that the structural changes in SF caused by the electrospinning process did not result in 
complete degradation of its structure as it could still rearrange into a similar structure to that 
seen in the degummed fibre upon solvent treatment.  
 
In addition to structural change, post treatment also serves as a method of removing excess 
electrospinning reagents. TFA is highly toxic to cells and any residue in the nanofibres could 
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result in cell death making the nanofibres unsuitable for tissue engineering applications. Chen 
et. al reported that TFA in SF-chitosan nanofibres forms salts with protonated amino groups 
and  exhibit  three FTIR  peaks in the region from 720 to 840 cm
-1
[218]. In their work, these 
peaks disappeared after treatment of the nanofibres with ammonia/ethanol solution, which 
indicated the complete removal of the TFA. The TFA salt peaks were not evident in our 
results thus suggesting the absence of any TFA in the nanofibres produced. However, there 
were new peaks seen in the spectral region between 1100 and 1210 cm
-1
after electrospinning 
where characteristic peaks of TFA are also found. If these peaks were indicative of TFA it 
would imply a significant amount of ‘free’ TFA would be present in the nanofibres. This is 
unlikely though as it would significantly impact the cytotoxicity results for the nanofibres 
considering the toxicity of TFA to cells. This toxicity was not observed for the cytotoxicity 
tests (Section 6.11) and it is therefore highly unlikely that these new peaks are attributable to 
excess TFA. Further research is therefore needed to identify the source and identity of the 
new peaks. 
 
6.6 Morphology of the treated nanofibres 
To further characterize the treated nanofibres, SEM imaging was used to view the effect of 
the different solvents on the fibre morphology. Generally, the solvents caused an alteration of 
fibre shape and a reduction of inter-fibre pores (Figure 6.10) when compared to the untreated 
electrospun fibres (Figure 6.3). Nanofibres treated with methanol were heavily fused and very 
brittle as evidenced by ‘cracks’ in the nanofibre mats (Figure 6.10d). This has been 
previously observed by other researchers and is attributed to a high crystalline content in 
methanol treated nanofibres [213]. Brittleness usually results in poor mechanical properties. 
Similar observations, in terms of reduction in the inter-fibre pores and brittleness, were seen 
with propanol and acetone treated nanofibres (Figure 6.10 a & c). Less brittle fibres were 
  
115 
 
observed with ethanol treatment compared to the other alcohols and also showed less 
reduction in the inter fibre pores (Figure 6.10 e). Chloroform treated nanofibres were almost 
completely degraded with individual fibres not evident in the SEM images (Figure 6.10b).   
FD-RSF and RD-RSF nanofibres did not show any major differences after treatment with all 
the solvents except with water vapour. The nanofibres prepared from FD-RSF were swollen 
and fused together, showing degradation of individual fibres (Figure 6.10f). In contrast, 
nanofibres from RD-RSF mostly maintained the circular shape of the untreated nanofibres 
and a smaller reduction of inter fibre pores (Figure 6.10g), most similar to ethanol treated 
fibres. Porosity is an important property for a tissue supporting scaffold, providing passage of 
nutrients to the growing cells and room for cell migration and proliferation. 
 
From the results, we can conclude that water vapour and ethanol are better solvents in 
maintaining the morphology and inter-fibre porosity of SF nanofibre mats. 
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Figure 6.10. SEM micrographs of SF nanofibres treated with a) acetone, b) chloroform, c) isopropanol, d) methanol, e) ethanol, f), water vapour (FD-RSF), and g) 
water vapour (RD-RSF) 
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6.7  Water solubility of SF nanofibres pre- and post- solvent treatment 
After solvent treatment, there was a visible improvement in the water stability of the 
nanofibres as they did not dissolve immediately after immersion in water and PBS solution. 
However, the differences in the structural transformation, as reflected in the FTIR studies, 
resulted in variations in water solubility of the nanofibre mats treated by the different 
solvents. Chloroform and acetone treated nanofibres completely dissolved within 12 h when 
immersed in PBS solution. The nanofibres treated with the other solvents showed better water 
resistance as they were virtually insoluble in water with less than 10 % weight loss after 
immersion for 7 days. It can be concluded that the higher content of β-sheets hinders 
penetration and interaction of water with the silk structure hence the increased stability.  
 
6.8 Thermal properties of silk nanofibres 
 Structural modifications induced by solvent treatment usually affect physical properties such 
as thermal behaviour of silk nanofibres. TGA and DSC analyses were used to investigate the 
thermal behaviour of the treated and untreated nanofibres. Chloroform treated nanofibres 
were excluded from further analyses because of the complete degradation of the nanofibre 
structure. Using TGA, the nanofibre samples showed a similar decomposition trend with 
around 10 % weight loss up to 200 °C (Figure 6.11). The weight loss continued steadily with 
increasing temperature and the nanofibres had lost at least 60 % weight at 400 °C. Figure 
6.12 shows the DTG curves which represent specific thermal decompositions accompanying 
weight losses of the SF nanofibres. 
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The first significant observed weight loss was around 220 to 227 °C which is attributed to 
breakdown of side chain groups of amino acid residues and as well as the cleavage of peptide 
bonds [313]. This occurs at a slightly higher temperature of 230 °C for the degummed silk 
fibre. The major weight loss associated with the degradation of the crystalline structure of the 
fibroin was observed between 320 and 340 °C for the nanofibres.  
 
The untreated and acetone treated nanofibres showed the fastest degradation (321 °C & 322 
°C respectively), which is an indication of lower thermal stability than the nanofibres treated 
with the other solvents. The solvents that showed the most transition to β-sheet structure 
(water vapour, isopropanol, ethanol and methanol) showed higher degradation at 332, 333, 
335 and 337 °C respectively. This supports the theory that the higher the crystallinity, the 
Figure 6.11. TGA curves of the untreated and solvent treated SF nanofibres 
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higher the degradation temperature. The maximum degradation of the degummed silk fibre is 
almost 30 °C higher, suggesting higher crystallinity in the native fibroin than any of the 
solvent treated nanofibres.  
 
 
Using DSC, more data could be obtained about the effect of the different treatments on the 
structure of the nanofibres. The initial weight loss observed for all samples at ≈ 80 ºC is due 
to loss of moisture. The weak endothermic shift around 168 ºC indicates the glass transition 
(Tg) of silk [347]. However, the Tg peak was not very evident in the graphs of the nanofibres 
treated with the other solvents indicating the presence of more β-sheets. Though there may be 
differences in peak temperatures, reports from various researchers indicate that endotherms 
seen around 242 ºC are attributed to molecular motion within the α-helix region and 
Figure  6.12. DTG curves for untreated and solvent treated SF nanofibres 
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crystallization of the random coil structure [305, 345, 348]. This was however observed at a 
lower temperature (228 ºC) for the degummed fibre. Weaker crystallization endotherms were 
observed for the alcohol and water vapour treated nanofibres as compared to the untreated 
and acetone treated nanofibres. The varied intensity of the peaks observed is probably due to 
the differences in the crystallinity imposed by the different solvents.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The more extensive transformation to β-sheets by these solvents restricts thermally induced 
motion of SF polypeptide chains [349] thus weak thermal transitions were observed in this 
temperature range. This clearly shows reduced α-helix and random coil content in these 
nanofibres. Overall, the DSC results show that the untreated and acetone treated nanofibres 
Figure 6.13. DSC analysis of treated and untreated SF nanofibres 
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mats were less thermally stable than the solvent treated nanofibres due to differences in 
crystallinity. The results are in agreement with data obtained using TGA as well as FTIR. 
 
6.9 Loading of resveratrol onto Gonometa SF nanofibres 
 
Considering the interesting chemical composition of Gonometa SF, we carried out a short 
study to assess its potential as a carrier for the bioactive phenolic compound resveratrol for 
wound care application. Resveratrol is mainly hydrophobic but the presence of the hydroxyl 
groups introduces the possibility of polar interactions, particularly considering the significant 
amount of polar groups in Gonometa fibroin. It is this dual hydrophobic and hydrophilic 
nature we sought to exploit in our attempt to evaluate the potential of Gonometa SF 
nanofibres as a carrier for the compound. Ethanol was used as a solvent as resveratrol is 
highly soluble in it and it is also a good solvent for inducing crystallization of silk fibroin 
matrices. In essence, in one reaction we attempted to simultaneously crystallize SF nanofibres 
whilst incorporating and stabilizing the resveratrol into the nanofibre matrix. The primary 
purpose of this study therefore was to examine the ability of Gonometa SF nanofibres to 
adsorb and stabilize resveratrol in one single easy step. 
 
Drug loading was determined indirectly by measuring the resveratrol remaining in solution 
after the adsorption experiments. Mass of the nanofibres instead of size was used in the 
experiments in an attempt to mitigate variances due to non-uniformity and porosity 
differences from sample to sample. All reactions were conducted in the dark with minimum 
exposure to light as it has been reported that resveratrol in solution can be unstable when 
exposed to elements such as light [350]. CE was used to determine the change in resveratrol 
concentration for the tests. Figure 6.14 shows the run time for the analysis was less than 5 
min with the resveratrol clearly resolved from the solvent peak. 
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6.9.1 Effect of contact time on loading of resveratrol  
We examined the influence of immersion time on the adsorption of resveratrol onto the 
nanofibres. A control containing just the resveratrol solution was analyzed parallel to the 
loading experiments to ensure stability of resveratrol under the experimental conditions in the 
study. Results for the control showed that the resveratrol content did not change significantly 
(at 5% confidence interval) and was sufficiently stable during the analysis. Aliquots were 
drawn at several intervals between 0 to 2 h. The loading occurred rapidly during the first 10 
min of contact as observed in Figure 6.15. There was no further significant adsorption 
observed after 20 min. It was thus assumed that 20 min was the equilibrium point and no 
significant amount of resveratrol could be adsorbed after that time. There were no significant 
differences seen for adsorption time when different concentrations of resveratrol solutions 
were used. 
Figure 6.14. CE analysis of 20 ppm concentration resveratrol using 30 mM phosphate buffer at pH 
8.0.  Conditions: Capillary, 30 cm effective length (total 37.5 cm) x 50 µm i.d; voltage +26 kV, 
temperature 27 °C; UV-Vis detection at 285 nm  
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CE electrophoregrams also revealed the reduction in peak area at different time intervals 
during the loading (Figure 6.17) which indicated adsorption of resveratrol onto the nanofibres 
had occurred. Our observations are similar to those reported by Baycin et al. where 
adsorption of phenolics from olive leaf was rapid in the first 5 min and the adsorption reached 
equilibrium around 40 min, though silk fibres instead of nanofibres were used in their work 
[351]. In the same work, the authors also concluded that the adsorption of the phenolics onto 
the surface of SF occurred via hydrophobic interactions [351]. 
 
Figure 6.15. Effect of contact time on adsorption of resveratrol on SF nanofibres using 20 ppm, 30 
ppm and 4 0ppm resveratrol solutions 
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Figure 6.16. Variation of peak area of resveratrol during loading onto nanofibres using 20 ppm resveratrol solution 
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Using ethanol, crystallization of SF nanofibres occurs within 15 min. We presume that this 
proceeded simultaneously with various hydrophilic and hydrophobic interactions being 
formed between the SF and resveratrol. It is thus possible that the resveratrol was also 
incorporated into the main silk structure during this process. Structure-activity relationships 
of polyphenols with biopolymers carried out by Tang et al. showed however that the 
interactions between the biopolymers and polyphenols were mainly hydrophobic when 
hydrophilic solvents were used and vice versa [352]. It is possible in this instance that as the 
resveratrol was present during the crystallization process; it may have formed hydrophilic 
interactions via hydrogen bonds with the SF molecules and thus incorporated into the main 
silk structure. To further study our assumption that the resveratrol may have incorporated into 
the main silk structure, we examined the adsorption of resveratrol on pre-crystallized 
nanofibres.  
  
6.9.2 Effect of pre-crystallization of nanofibres on loading of resveratrol 
Pre-crystallized nanofibres were prepared by immersing the nanofibre mats in ethanol for 15 
min and then drying under vacuum for 24 h. The dried nanofibres were then immersed in 
ethanolic resveratrol and the analysis done in the same way as for the uncrystallized 
nanofibre mats. Results showed that the decrease of resveratrol in the test solution (Figure 
6.17) was less than that observed for the uncrystallized nanofibre mats (Figure 6.16). This 
suggests that loading capacity of pre-crystallized nanofibres is less than that of uncrystallized 
nanofibres, thus supporting our theory that the resveratrol is incorporated into the main silk 
structure during crystallization of the silk nanofibres.  
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6.9.3 Effect of initial solution concentration on loading of resveratrol 
 Loading of resveratrol onto the nanofibres was investigated over a concentration range of 10 
to 50 ppm as shown in Figure 6.18. Results did not clearly show any loading of the 
resveratrol when 10 ppm resveratrol solution was used. The lower concentrations may have 
been insufficient for significant interactions with SF. High variance also seen at 10 ppm may 
have also been compounded by poor instrument response at low concentrations. When higher 
concentration of 20 ppm was used, there was an increase in the incorporation of resveratrol 
into the SF nanofibres (Figure 6.18b). Again it was noted that the concentration rapidly 
decreased within the first 15 min where crystallization of the random coil segments in the SF 
occurs. This suggests that the availability of more resveratrol molecules during crystallization 
increased the loading onto the nanofibres. 
Figure 6.17. Adsorption of resveratrol on pre-crystallized SF nanofibres using 40 ppm 
resveratrol solution 
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Figure 6.18. Effect of initial concentration on loading resveratrol onto SF nanofibres a) 10 ppm, b) 20 ppm, c) 30 ppm, d) 40 ppm and e) 50 ppm 
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Similar results were obtained using silk fibres and olive oil polyphenols. The authors reported 
a significant increase in the adsorption of the olive plant phenolic oleuropein was observed 
when its initial concentration in solution was increased [351].  
 
The most resveratrol incorporated into the SF nanofibres was when 30-50 ppm solutions were 
used and the adsorption ranged from 8 to18 µg/mg of nanofibre. The large variances seen in 
the amount of resveratrol adsorbed can be attributed mainly to non-uniformity of the 
nanofibre mats in terms of porosity and fibre diameter. This makes it a challenge to optimize 
and standardize loading of the compound onto the nanofibres via adsorption. The results 
however show that a more thorough and extensive study of the exact type and extent 
interactions between resveratrol and SF under the conditions utilized in this work still need to 
be done to optimize the process. Upscaling the process to use larger amounts of the 
nanofibres may also help in providing better results. 
 
6.10 Release of resveratrol from the nanofibres 
Release studies are important for a drug delivery scaffold to determine delivery rate of the 
drug to target organs. The release of compounds embedded in SF matrices is determined by 
characteristics of both the incorporated drug and SF such as nature and size of the compound, 
degree of crosslinking and pore size of the SF matrix [353-355]. The release of resveratrol 
was evaluated in phosphate buffered saline (PBS) at pH 7.4. PBS was selected for the release 
studies to closely simulate human physiological pH condition of 7.2–7.4 and would therefore 
give an indication of release of the resveratrol under when in contact with physiological 
fluids. However, there was no evidence of release of any resveratrol from the SF nanofibres 
and this could be due to a number of reasons. Firstly, it is possible that the larger amount of 
resveratrol is actually incorporated into the main silk structure and release is not possible. 
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There have been reports of polyphenols interacting irreversibly with some dietary proteins 
[356]. It is also possible that, as resveratrol is a photosensitive compound, surface interactions 
may have not been sufficient enough to stabilize the compound and it therefore degraded 
hence no compound was present to be released. The adsorbed quantity could also have been 
too low.  
FTIR studies could also not confirm the presence of any new interactions in the SF 
nanofibres (Figure 6.19). Characteristic peaks of resveratrol found at 966, 1383, 1585 and 
1607 cm
−1
 [357] are in amide regions where the SF itself exhibits peaks and therefore no 
conclusive evidence was presented using this technique. The absence of these characteristic 
peaks is however not a clear sign that the resveratrol is not present in the nanofibres. 
Murugesh & Babu reported similar results with SF and curcumin [358]. They attributed the 
absence of signals to either one or a combination of the following phenomena. Firstly, the 
compound could simply have not been adsorbed on the surface of scaffold; rather, it possibly 
interacted with the core pockets of fibroin. The interactions of the compound with fibroin 
could be via noncovalent bonds and would therefore not exhibit any new peak or significant 
shift in peaks. It is also possible if interactions with the compound occurred in the regions of 
amide moieties or β-sheet components, it could lead to a decrease in the intensity of 
corresponding characteristic signals [358]. 
Crystallographic techniques of samples with and without resveratrol may provide more 
information to help understand interactions between the SF and resveratrol. 
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6.11 Cytotoxicity of nanofibres 
Biomaterials may have different levels of potential risk to humans depending on the type and 
the extent contact with a patient. It is therefore imperative to assess cytotoxicity of new 
biomaterials.  
 
 
 
 
 
 
Figure  6.19. FTIR spectrum of resveratrol-SF and plain SF nanofibres 
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According to the cytotoxicity grading for the study, low hazard or non-toxic materials present 
a 50% of cell growth inhibition (IC50) at a concentration greater 100 µg/ml of the test 
material. Results showed IC50: >100 µg/ml for plain and resveratrol-loaded nanofibres whilst 
IC50 for the etoposide standard was 5.1 µg/ml. These results indicate that the plain and 
resveratrol-loaded silk nanofibres produced were not toxic to cells presenting at least 98% 
cell viability (Table 6.4). The cell’s viability for the resveratrol loaded silk nanofibres was 
practically the same as positive control (cells, no drug) for highest concentration tested. We 
can therefore conclude that Gonometa nanofibres qualify as a non-toxic biomaterial. 
 
 
Table 6.4.  Cytotoxicity of SF nanofibres, and etoposide 
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6.12 Antibacterial, antioxidant and anticancer properties of resveratrol loaded silk 
nanofibres 
 Antibacterial, antioxidant and anticancer properties of the nanofibres was also examined. 
Despite the inconclusive results on the release of the resveratrol, it was necessary to carry out 
these tests as some clinical studies have revealed resveratrol to produce positive results even 
though the active resveratrol was not measurable [359]. However, negative results were also 
obtained for the tests.  
For the antibacterial tests, a simple disc diffusion method was used to determine the 
susceptibility of S. aureus (gram positive) and E. coli (gram negative) to the nanofibre 
samples. The activity of the antimicrobial is determined by observing zones of no bacterial 
growth around the sample. Both the plain and resveratrol-loaded nanofibres did not show any 
inhibition zone indicating the antimicrobial effect was either very ineffective or non-existent 
against the bacteria used in the study. 
 
For the antioxidant tests, gallic acid which possesses good radical scavenging properties was 
used as a standard. According to criterion used for the experiments, a sample is considered 
inactive if radical scavenging is < 80% for a concentration of 100 µg/ml. Both the nanofibre 
samples can therefore be considered to have no useful antioxidant properties as they showed 
significantly less activity than the reference compound, gallic acid (Table 6.5). 
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TK10 (renal), UACC62 (melanoma) and MCF7 (breast) cancer cells, were used to assess 
anticancer activity of the nanofibres. TGI (total growth inhibition) signifies a cytostatic 
effect. Samples are considered inactive if parameter TGI for two or three cell lines is higher 
than 50 µg/ml and potent activity (TGI <6.25 µg/ml). Therefore, both the plain and 
resveratrol-loaded nanofibres can be considered inactive against cancer cells (Table 6.6).   
Table 6.5. Antioxidant activity of SF nanofibres and gallic acid 
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Table 6.6.  Anticancer activity of SF nanofibres against three cancer cell lines 
 
 
 
 
 
 Etoposide Plain SF nanofibre Resveratrol loaded  SF nanofibre 
Conс, 
µg/ml 
Cell 
Growth,%  
TK10 
Cell 
Growth,% 
UACC62 
Cell 
Growth, % 
MCF7 SD 
Cell 
Growth,%  
TK10 
Cell 
Growth,% 
UACC62 
Cell 
Growth, 
% MCF7 SD 
Cell 
Growth,%  
TK10 
Cell 
Growth,% 
UACC62 
Cell 
Growth, % 
MCF7 SD 
100 -52.14 -44.87 9.48 0.003-0.023 134.02 76.93 86.34 0.009-0.068 102.18 58.48 64.56 
0.017-
0.021 
50 -43.33 -31.63 13.19 0.001-0.017 123.36 95.62 98.83 
0.023-0.063 
112.46 82.45 87.41 
0.005-
0.045 
25 -10.39 6.43 20.16 0.003-0.033 119.38 99.85 97.25 
0.015-0.051 
105.03 89.73 94.63 
0.037-
0.090 
12.5 19.71 20.56 27.23 0.006-0.015 117.52 99.40 113.34 
0.003-0.241 
101.59 97.90 98.24 
0.002-
0.044 
6.25 43.58 26.39 34.13 0.008-0.015 111.90 107.74 99.06 
0.072-1.330 
99.78 97.11 98.69 
0.046-
0.063 
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We can thus conclude that using the experimental conditions in this study, SF nanofibres did 
not perform well as a carrier for resveratrol for drug delivery purposes.  
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CHAPTER SEVEN 
CONCLUSIONS AND FUTURE PERSPECTIVES 
7.1 Introduction 
The gap in the information concerning the properties as well as biomaterial applications of 
fibroin from African silkworm species led to the research conducted in this thesis. This 
chapter presents the conclusions drawn from the work under each of the objectives set out at 
the beginning of the study. Although this research has addressed most of the set objectives, to 
further understand and develop fibroins from African silkworm species as biomaterials, 
further work is needed. Recommendations put forward for future work encompass work not 
done due to unavailability of some facilities during the study as well as questions that arose 
during the study.   
7.2 Conclusions 
Silk fibroin from G. rufobrunnae, G. postica, A. mimosae, E. bahuniae and A. panda 
silkworm species was successfully characterized. Much like most fibroins, the major amino 
acids were glycine, alanine and serine which promote formation of extensive β-sheet 
crystalline structures. A. panda was the most crystalline amongst the fibroins with a very 
unique composition consisting almost entirely of glycine and alanine. G. rufobrunnae, G. 
postica, A. mimosae and E. bahuniae fibroin are potentially more reactive than B. mori and A. 
panda fibroin due to a higher polar amino acid content. A. mimosae and E. bahuniae SF 
showed similar characteristics to those reported for species in the Saturniidae family. The 
chemical composition had a significant influence on the physical properties of the fibroins 
with differences observed in thermal and mechanical properties of the fibroins. Overall, the 
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differences in properties between the African silk fibroins and B. mori fibroin can offer 
diversity in their application as textiles and biomaterials.   
The fibroins have different solubilities mostly dependant on the type and concentration of the 
salt.  Aqueous LiBr and Ca(NO3)2 solutions were good solvents for Gonometa fibroin with 
just over 20 % (w/v) solutions obtained. Contrary to reports for other species, incorporation 
of organic solvents into aqueous LiBr and Ca(NO3)2 solutions reduced solubility of 
Gonometa fibroin. The solvents examined in this study were however not of practical use for 
the quantitative dissolution of A. mimosae, A. panda and E. bahuniea fibroin. This suggests 
the dissolution of silk is governed by several factors including the structural characteristics of 
the individual fibroins.  
Electrospinning was successful in producing nanofibres from Gonometa RSF using 
trifluoroacetic acid as a solvent. This achievement sees the first time a biomaterial scaffold is 
prepared from this species. SF concentration was the most significant parameter in producing 
uniform and continuous fibres. The choice of solvent was also influential as trifluoroacetic 
acid electrospun at lower concentrations than formic acid and no electrospinning was 
observed using water. Other parameters such as the applied voltage, tip to collector distance 
and the feed rate had more impact on the morphology and diameter of the nanofibres 
produced rather than electrospinnability. At optimum conditions (0.05 mL/h flow rate, 10 cm 
tip to collector distance and an applied voltage of 15 kV), nanofibres with diameters ranging 
from 400-1000 nm and 300 to 760 nm using FD-RSF and RD-RSF respectively were 
produced. FD-RSF and RD-RSF were mainly composed of β-sheets, similar to the 
degummed fibre. Electrospun nanofibres showed reduced β-sheet content when compared to 
degummed fibroin and RSF resulting in poor physical properties as well as solubility in 
water. The type of solvent can be used to tailor the nanofibre material properties as the extent 
of crystallinity induced varied depending on the solvent. The more crystalline nanofibres 
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exhibited higher thermal degradation temperatures. Ethanol and water vapour were the most 
effective in inducing crystallinity whilst maintaining the physical integrity of the nanofibres. 
Despite restoration of crystalline structure in the nanofibres, they still exhibited differences in 
thermal properties compared to the degummed silk fibre thus showing organizational 
variances in their structures.  These findings were confirmed by shifts in FTIR peaks, 
reduction in crystalline peaks in XRD scatterings and drop in endotherms in DSC 
thermograms. 
Cytotoxicity tests showed Gonometa SF nanofibres were non-toxic to cells thus indicating 
potential for applications requiring biocompatible materials. Further experiments were 
performed to assess the nanofibres as a carrier for the drug resveratrol with the aim of 
developing an antimicrobial wound dressing. Using ethanol as a solvent, resveratrol loading 
onto the SF nanofibres was a maximum of 18 µg/mg of nanofibre with over 95 % of 
resveratrol adsorbed within 15 min. An increase in the initial resveratrol concentration 
increased uptake of the compound into the SF nanofibres. While the nanofibres did not 
display ability to release the resveratrol, the overall results encourage further investigations 
into the developed Gonometa SF nanofibres as a drug delivery vehicle. Primary composition 
is therefore not a direct indicator of functionality in silks, and the search for correlations 
between microstructure and properties still remains an important endeavour. 
In summary, the work presented in this thesis has enabled a more detailed understanding of 
the structure of SF from African silkworm species and their potential as biomaterials as 
exemplified by Gonometa SF nanofibres. As these are the first time studies for SF from 
African species as biomaterials, there is great potential for their properties to be exploited for 
various tissues and applications. 
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7.3 Future Perspectives 
1. Studies to determine the sequencing of the proteins will be helpful in providing more 
insight into the nature of the fibroins as well as provide information that can be used 
for genetic engineering of valuable segments of the proteins. This is important 
considering one of the challenges that could hinder the use of SF from wild African 
silk species is lack of continuous supply as their population dynamics are still being 
established.  
 
2. While appreciable progress was made by producing Gonometa SF nanofibres, a lot of 
work remains as the rest of the fibroins were not investigated as biomaterial scaffolds. 
Further studies are required to fully understand the dissolution process of fibroin and 
to also determine solvents suitable for the other fibroins in order to produce RSF 
needed to fabricate the biomaterial scaffolds. Ionic liquids have proven to be very 
effective solvents for various natural polymers that are difficult to dissolve and it 
would be interesting to investigate them as candidate solvents.  
 
3. Drug loading is a promising objective to extend the applications of the Gonometa SF 
nanofibres, especially considering its hydrophilic moieties. In addition to the 
resveratrol, other bioactive molecules with differing characteristics such as size, 
hydrophobicity or water solubility should be investigated to further understand the 
interactions with SF. The knowledge of these interactions may lead to better control 
of the loading and release processes of the incorporated components thus enabling 
further development of the ideas introduced in this study. In addition, release data can 
be assessed with various models to appropriately determine the release mechanism 
and kinetics. Determination of adsorption isotherms will also provide important data 
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as the isotherms give insight into the interactions and the maximum capacity of the 
adsorbents. 
  
4. Different morphologies such as nanoparticles, hydrogels can be developed from the 
African fibroins and investigated for different applications. This will also be 
beneficial in identifying how the different constructs affect drug loading and release if 
used for drug delivery. 
  
5. Mechanical properties of the fabricated nanofibres should be investigated to 
determine the load bearing capabilities of the nanofibres.  
 
6. Biodegradation and cell interaction studies of the SF nanofibres would be valuable in 
cementing the biomaterial status of the Gonometa SF nanofibres and extend their 
applications for various tissues. 
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